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ABSTRACT
In this study, I conduct a multiple method content analysis of literature on postpartum
depression (PPD) from two on-line sources, Medline and LexisNexis. The purpose of the
study is to determine how the medical profession defines and frames PPD, and to
consider the implications of its movement into the medical model. I use the theories of
Foucault, Gramsci, critical constructionism, and postmodern feminism to examine the
effect of the medicalization of PPD on women’s lives. Using both simple descriptive
statistics and qualitative analysis, I show the expansion of medical control over women’s
bodies in the childbearing years beyond the physical to include the emotional and
psychological aspects as well, which results in standardized maternal behaviors and
emotions that tighten the boundaries of motherhood.
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CHAPTER 1
INTRODUCTION
In June, 2001, Andrea Yates committed the unthinkable when she purposefully
and methodically drowned her five children in a bathtub (Hamill 2001). The shocking
news of this tragedy inundated television broadcasts, newspapers, magazines, tabloids,
and radio. Perhaps the most shocking aspect of the tragedy is that Yates transgressed
every traditional notion about motherhood. She was charged with murder and faced a life
sentence or possibly the death penalty. Her defense attorneys claimed Yates suffered
from temporary insanity due to postpartum depression (PPD), a condition which is the
disease du jour associated with pregnancy and childbirth. Although extreme, this case
has become the hallmark for the potentially dangerous malady, prompting families and
medical professionals to be alert to symptoms after the birth of a new baby. Public
awareness of PPD was heightened in 2005 when Tom Cruise, an actor and a member of
the church of Scientology, publicly denied the benefits of medicating women with PPD
and discredited the field of psychiatry in general. He criticized actress/author Brooke
Shields for her use of antidepressants during her recovery from PPD, provoking an
exchange of opinions about the postpartum condition.
But what exactly is postpartum depression? Is it a disease? Does it have
biological roots – such as the dramatic change in hormones that occurs after giving birth
– or social causes – such as lack of support in the motherhood role? Is it a real condition
or is it a myth? Information in both medical and popular sources portrays similar
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characterization of the symptoms and treatments of the condition; however, a clear
understanding of the causes of PPD is lacking. Without knowing the causes of PPD,
medical professionals devise treatments aimed at alleviating symptoms. Such treatments
typically include antidepressants or psychiatric counseling, or a combination of both
(Puckering 2005; National Institute of Mental Health 2002; The National Women’s
Health Information Center 2002).
This study examines how the medical profession defines and frames PPD through
a content analysis of articles contained in Medline, an on-line source for medical
knowledge contained in the database of the U.S. National Library of Medicine (NLM),
and with articles contained in the general news portion of LexisNexis. The articles on
Medline are generally written by medical professionals – doctors, nurses, psychiatrists,
medical researchers, PhD’s, and others, and Medline is a particularly important source for
analysis because of the authority which scientists and doctors wield. Analysis of the
articles on LexisNexis allows for a comparison between “scientific” and “lay” press
representations of PPD. Medline contains over 700 articles on PPD extending from 1950
to the present, and LexisNexis contains over 1700 articles for the same time period. To
keep the study manageable, I examine a sample of articles chosen in five-year
increments, beginning with 2005, then working back to 2000, 1995, 1990, and so on,
back to 1950. Examining the articles in five-year increments reveals changing definitions
and frames over time, illustrating the increasing medicalization of PPD.
This study is important for several reasons. First, medicalization, a process which
“organizes a broad and ever growing range of behaviors and aspects of everyday life into
categories of health and illness” (Haritty & Tiefer 2003: 43) can be a means of social
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control, promoted by medical experts and/or pharmaceutical companies with the ulterior
motive to benefit professionally or economically from including PPD in the field of
medicine (Haritty & Tiefer 2003; Conrad 1992). Second, the medicalization of women’s
issues, visible in such life events as childbirth, PMS, menopause, and increasingly
postpartum depression, among others, tends to pathologize women and “reframes
women’s experiences of their own lives and bodies” (Haritty & Tiefer 2003: 44). For
example, Murphy-Lawless (1998), in Reading Birth and Death: A History of Obstetric
Thinking, chronicles the medicalization of childbirth, illustrating the power that scientific
knowledge has in shaping women’s experiential knowledge of the birth process.
Presenting women’s bodies as faulty, medical experts promoted their science as a means
of lowering the risk of death for mother and baby (though it did not), which gave greater
control to obstetric practices and greater authority to male-midwives and, later,
obstetricians. These practices “produced a complete scheme of labor management in
1920” (Murphy-Lawless 1998:172) which is still practiced today, including that the
hospital remains the preferred place of birth, that obstetricians use forceps when
necessary or convenient, and that the typical birth position is horizontal and immobile. In
addition, episiotomies are routinely performed, drugs are available to ease the pain of
labor, and the c-section rate is at an all-time high – 29.1percent of all births (Rubin 2005).
Third, just as the medical profession uses fear to gain women’s compliance with
obstetrics, analysis of the articles reveals that fear – of harm to the child, to the mother, to
the family– is used to gain acceptance of PPD as a medical issue. And finally, the
articles reveal the extent to which other family members are considered vulnerable to
PPD, expanding the scope of postpartum depression beyond the mother.
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THEORETICAL BACKGROUND
The theories of Foucault and Gramsci are applicable to the medicalization of
PPD, as are critical constructionism and postmodern feminism. Foucault asserts that
truth is constructed through discourse in the activities of everyday life, and that nothing
has meaning outside of discourse. Individuals create and subscribe to regimes of truth,
discursive formations that carry an assumption of authority with the power to deem
knowledge as true or false, and they discipline and manage their bodies in order to
perform according to these beliefs (Foucault 1979).
The transformation to docility is achieved through disciplinary technologies that
create the knowing, the knowable, and the self-knowing individual. First, hierarchical
observation categorizes, distributes, and creates a definition of what is normal or not
normal, and the transformation of individuals to knowing individuals requires awareness
of definitions of what is normal or not normal. Second, normalizing judgment allows
understanding of self through biology, economics, and linguistics, with objectification of
the body-as-thing complemented by the dividing practices instituted in spatial, temporal
and social compartmentalizations. Normalization is evident in national standards for
educational programs, medical practices, and industrial processes and products. And
third, examination occurs as the individual turns self into subject, undergoing a process of
self-understanding mediated by an external authority figure such as doctor,
psychoanalyst, or priest (Foucault 1975). In contemporary societies, discourse becomes
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an effective means of social control, instrumental in managing conformity through its
normative operations. The process of separating the normal from the abnormal for the
purpose of treating the abnormal serves as an enforcement of conformity for the normal
rather than as punishment for the abnormal (Rabinow 1984).
Similar to Foucault’s notion of conformity through docility, Gramsci’s notion of
hegemony indicates the willing acceptance of one social group’s dominance and control
by another through ideologies which become “common sense” in everyday practice.
Gramsci maintains that power lies in the ability to gain willing participation through a
combination of coercion and leading. Political society, or the state, projects ideological
beliefs that make individuals feel connected and think that they have something to gain in
preserving order. Civil society enforces the belief that individuals have something at
stake and invokes conformity through the institutions of the family, the church, the
media, education, and others. Self-identity is formed through association with these civil
institutions which serve to control individual desires and impulses. Coalitions, rather
than class consciousness, reflect how individuals make sense of their own lives based on
shared beliefs, values, and commitments. Similar to Foucault’s “expert eyes,” Gramsci’s
concept of hegemony is political power that flows from intellectual and moral leadership
to build consensus, which is a move away from physical control over the body to
conformity through the individual’s willing participation. “Articulation” is the political
process by which individuals redefine their identities, which are not static but fluid and
constantly changing. Individuals often choose to participate because “experts” deem
certain actions to be in the individual’s best interest. Additionally, the knowledge of
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experts informs social policy which becomes the predominant course of action (Seidman
2004).
A third theoretical position that is applicable to the PPD issue is critical
constructionism, a synthesis of conflict theory and social constructionism that focuses on
how the meanings of social problems are constructed. Critical constructionism maintains
that elite interests determine which phenomena are problematic; provide explanations for
the causes of the phenomena; and persuade the public that the phenomena are
problematic and, therefore, require action (Heiner 2002:9). Influenced by corporate
sponsorship and driven by profits, the media serve as vehicles for influencing public
opinion. By reporting on social problems caused by the less powerful but deflecting
reports which implicate wrongdoing by their corporate sponsors, the media participate in
shaping public response to social problems. Critical constructionism recognizes an
imbalance of power between the elite and those with the least amount of power in
society. From this theoretical perspective, those in power exert their influence to
maintain the status quo, allowing their continued dominance.
Postmodern feminism, which seeks not only to include women in research but to
deconstruct hierarchically informed knowledge and power (Hesse-Biber and Yaiser,
2004), is also relevant to my topic. Postmodern feminism is concerned with giving
women the same rights as men, but recognizes that race, class, ethnicity, gender, and
sexuality intersect to create multiple consciousness and to affect social structure. The
intent of postmodern feminism is to create resistance to the status quo and interrupt
power-knowledge relations:
Postmodern feminists often use texts (in varied forms), the products of
dominant culture and signs of postmodernity, in conjunction with the view
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of the oppressed, as the starting point of cultural interrogation…not in order to
reconstruct another view of the social world (an exercise in power and
colonization) but rather to unravel the social processes and relations that have
constructed the social world in hierarchical ways. (Hesse-Biber and Yaiser
2004:19)

METHODOLOGY
For this study I conduct a multiple method content analysis of literature on PPD
from two on-line sources, Medline and LexisNexis. The purpose of the study is to
determine how PPD is framed by the medical community and how it is represented in
medical literature compared to general news. I use simple descriptive statistics to
illustrate its movement to the medical model, including the most common causes, effects,
and recommended treatments. For the qualitative analysis, I examine the discursive
elements shaping PPD as a disease by noting the authors’ descriptions of PPD, of
motherhood, and of the role of medical professionals. The importance that language
plays in social life is the basis of the qualitative analysis, and the articles serve as
narratives from which one can understand how the medical profession frames the issue of
PPD. My intent is to examine the scope of discourse on PPD, noting the most common
themes as well as those that are infrequent but informative indicators of PPD in medical
and non-medical contexts, revealing ranges and patterns of defining PPD.
For example, in my notes several of the authors mention the need to screen
mothers for depression beyond the traditional 6-week postnatal checkup because of the
possibility that depression can occur later, and others suggest that depression may begin
in pregnancy and suggest that screening begin before delivery. Combining the
information on the prescribed periods of screening exposes the range and pattern
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recommended by the authors and brings the realization that the postpartum period is
being redefined as a longer timeline, extending to three months, six months, one year,
two years, five years beyond delivery, as well as extending back into pregnancy. This
finding adds depth to our understanding of medical control over the procreative process
and its effect on women’s lives, a finding that would have been missed with the
quantitative study alone.

Data Collection
There are over 700 articles on PPD on Medline to date and, as previously noted,
to keep the analysis manageable I select a sample from the articles in five year
increments, starting with 2005 and proceeding back to 2000, then 1995, 1990, 1985,
1980, and 1950. There are no articles between 1980 and 1950, and the bulk of the
Medline articles were printed in 1995, 2000 and 2005. After eliminating articles that
were only available in a language other than English, as well as one article that had been
withdrawn from publication, I chose to keep all of the articles from 1950 (1), 1980 (2),
1985 (2), and 1990 (14) in my sample. Medline has a total of 22 articles on PPD
published in 1995, and 27 in 2000, of which I eliminate every third article so that a total
of 14 articles represent the year 1995 and 18 articles represent the year 2000. In 2005, a
total of 87 articles were published in Medline, and I select every fourth article for
inclusion for a total of 18 articles from 2005. Thus, the total number of Medline articles
on PPD in my sample is 69, and the number representing each year of my study is fairly
even.
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In addition to the Medline articles, there are 127 articles on PPD (as of November
2006) in the general news section of major newspapers in the LexisNexis database for the
same years as the Medline articles. The bulk of the LexisNexis articles were printed in
2005, most centering around the disagreement between Brooke Shields and Tom Cruise
over the legitimacy of PPD. Again, I keep all of the articles from 1980 (2), and 1990 (1)
(there were no articles printed in 1985), but select a stratified random sample from the 12
articles printed in 1995, the 31 articles printed in 2000, and the 81 articles printed in
2005. For 1995, I eliminate every third article; for 2000 and 2005 I include the first
articles and every fourth article thereafter. The total number of LexisNexis articles is 40,
bringing the total number of articles in my sample from both databases to 109.
Examining the articles in five year increments allows an analysis of changes in frequency
and representations over time.

Coding
To facilitate coding for the quantitative portion of this study, I devised a code
sheet (Appendix A) with nine sections. Section 1 includes identification of the article by
number, database, and year published. Section 2 includes information on the author,
including name, gender, and credentials (MD, PhD, PsyD, RN, LPN, LCSW, LPC, and
others). It also includes sponsorship of the article, such as pharmaceutical company,
medical practice, or professional organization, if available.
Section 3 references the etiological definitions of PPD, including its causes:
biology (hormones, sleep deprivation, diet, and others), psychology (prior depression,
coping skills, perfectionism, low self-esteem, childhood experience), and social (family
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support, marital relationship, friends). Section 4 examines whether the article implicitly
or explicitly infers that some groups are more vulnerable or at risk for experiencing PPD
because of biographical characteristics (age, marital status, class, race, or ethnicity).
Section 5 codes for symptoms of PPD, including physical (insomnia, no
energy/fatigue, appetite changes, headaches, chest pains, heart palpitations,
hyperventilating); emotional (anxiety, excessive worry, confusion, sadness, feeling
overwhelmed, feeling inadequate as a parent, incoherence, feeling of hopelessness,
thoughts of suicide, hallucinations); or behavioral (crying, oversensitivity, irritability,
panic attacks, hostility, paranoia). Section 6 examines the intensity (baby blues, PPD, or
postpartum psychosis) and prevalence (in terms of percent of new mothers who have
baby blues, PPD, or postpartum psychosis), and whether the article suggests that others
can have PPD (fathers, other family members, friends). Vulnerability of fathers and other
family members would implicate social rather than biological causes.
Section 7 codes for suggested treatments for PPD, including medication,
counseling, social support, or a combination of the above. Section 8 codes whether the
article uses fear to promote PPD as a disease by mentioning consequences of PPD (harm
to child, harm to mother, harm to spouse, harm to family, harm to society), and whether it
mentions extreme cases of PPD such as Yates. And Section 9 codes for whether the
article advocates proactive intervention of medical professionals through screening (of
new mothers, new fathers), educating (mothers, fathers, health care professionals), or
supporting (new mothers, new fathers, or health care professionals). The final section
allows for comments or quotes that inform the qualitative analysis of the articles.
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Test-Retest of Reliability
For this analysis I draw upon coding categories that were reasonably clear cut and
I strove to make the coding categories as concrete as possible to increase coding
reliability; thus no additional coders were necessary. Some time after I completed
coding, I selected one out of every 20 articles to check the test-retest reliability of the
coding process, recoding a total of five articles. By making the coding categories as
concrete as possible, I minimized (but not eliminated) the threat to reliability; the answers
on the recoded articles were very consistent at an average of 98 percent.

Limitations of the Study
Perhaps because of commercial reasons, LexisNexis adds articles to its database,
not because new articles are written as time goes by but rather articles from the same
historical time period are added at later dates. Methodological implications include that
the study would be difficult to replicate, as a researcher who today searches in
LexisNexis for articles on postpartum depression in the general news section of major
newspapers would find vastly larger sets of text than those included in my sample. Also,
the few articles written before 1990, although extremely helpful in revealing the
increasing focus on PPD, provide few cases from which to compare percentages (e.g., of
authors who recommend social support as treatment) to later articles. For instance, 50
percent of articles in my sample from 1980 include two out of four, whereas 50 percent
of articles in 2005 include 19 out of 38. Therefore, although the percentages are the
same, many more authors are in agreement in their representations of PPD in the later
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years. Despite these limitations, I think these materials provide rich textual sources for
understanding the medicalization of postpartum depression.

CHAPTER 2
LITERATURE REVIEW
Murphy-Lawless (1998) chronicles the movement of childbirth into the medical
model, in which medical intervention and obstetrical practices came to be accepted as the
norm. The male-dominated field of obstetrics offered empirical, scientific knowledge of
the childbirth process which gradually replaced women’s experiential knowledge. The
risk of complications and/or death of the child or mother became the impetus for
surrendering agency over to medical experts in the birthing process (Murphy-Lawless
1998). Further, Murphy-Lawless asserts that the firm entrenchment of scientific
“evidence” and the authority of the medical profession make it difficult to reclaim agency
in the birthing process. She finds that the sociological struggle between the patriarchal
male as hero and the (presumed) physically and intellectually incapable woman is clearly
visible in the childbirth arena, which delineates the concept of knowledge as power,
dominance by the knowing individuals (obstetricians), and subjugation of women in
childbirth.
Similarly, Goer (1999) echoes the view that obstetrics empowers the mostly maledominated field of experts while it discounts women’s knowledge, intuition, experience,
and role in the birth process. Goer states:
The typical obstetrician is trained to view pregnant and laboring women as a
series of potential problems, despite the fact that pregnancy and childbirth are
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normal physiological processes that are no more likely to go seriously wrong
than, say, digestion. (Goer 1999: 3)
Both Goer and Murphy-Lawless reject the obstetrical belief that women’s bodies are
weak and need the obstetrician’s medical intervention to rescue the baby from the
mother’s body. They posit that although scientific claims to objectivity and expert
knowledge and practices are illusions, individuals nevertheless surrender agency to the
experts in charge of medical care because of the legitimacy accorded to science.
A body of literature suggests that the subjugation of women continues in
motherhood, beginning during pregnancy when many social controls are placed on the
pregnant woman. Through the discourse of endangerment, the period of pregnancy is
structured as part of the extended timeline of childhood, removing the focus from the
woman and placing it on the developing fetus (Rothman 1982; Brooks Gardner 1994).
The perception of childhood beginning before birth expands the mental construct of when
life begins, setting temporal boundaries (Zerubavel 1991) that have profound political
implications such as a tension between rights of the “fetus-infant” and the reproductive
rights of the woman (Isaacson 1996: 472). The rhetoric of endangerment places sole
responsibility on the woman to gain expert knowledge and to act responsibly so that a
healthy infant results from the pregnancy (Rothman 1982; Brooks Gardner 1994:72).
Socialization, through both medical experts and popular sources, obligates the pregnant
woman to regard the fetus’s health as more important than her own and to center every
action, thought, and ingestion on giving the fetus every possible chance for optimum
development.
In the United States, a woman’s behavior during pregnancy becomes subject to
many measures of control that emphasize the indirect consequences of her
actions, thoughts, and feelings on the malleable fetus, which requires the
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pregnant woman to self-impose restraints for the future good of the child. (Brooks
Gardner 1994:71)

Some literature suggests the medicalization of women’s emotionality, resulting in
greater numbers of women diagnosed with depression. Stoppard (2000) asserts that
women more often than men are socialized to use coping strategies such as forbearance
and negotiation, which are often characterized as passive, problem-avoidant, emotionfocused, and viewed as deficits. The androcentric focus of psychiatric norms places
women at greater risk for “atypical depressions” that include anxiety/depression
syndrome rather than the DSM-IV specified symptoms of Major Depressive Disorder
which typify mostly men with depression (Stoppard 2000).
Similarly, Shields (2002), in a study of stereotypical gender differences in
emotionality, posits that women’s emotional expressions are often connected with
weakness, making women more vulnerable to the dominance of medical experts.
Bilirakis (2004) adds a biological root to depression, suggesting that hormonal factors
contribute to the increased rate of depression among women, which is approximately
twice the rate of depression among men. Stoppard and McMullen (2003) and Mauthner
(2002) implicate social reasons for the increased rate of depression among women,
arguing that women’s depression is caused by cultural proscriptions about the “good
mother” which prevent women from expressing any negative feelings about mothering.
Others support this ideological argument, suggesting that discourse surrounding
motherhood bolsters cultural expectations that having a baby should be a happy time in a
woman’s life (Kaur 2004; Meltz 2003; Smith 2004). Depression results because the
reality of motherhood often contrasts sharply with idealized constructions of motherhood
(Mauthner 2002).
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Mothers themselves, anxious to live a Gerber commercial, may feel ashamed
or guilty about having any negative thoughts. . . . Antidotes for postpartum
depression begin with an awareness of symptoms: excessive worry about
caring for the baby; teariness; anxiety or panic; inability to sleep when the baby
sleeps; difficulty doing regular tasks; inability to take pleasure in the baby. (Meltz
2003)

Greater publicity around sensationalized cases, such as that of Yates, increases
public awareness and concern and results in increasing numbers of women identifying
with the symptoms as suggested by the experts. The news of “normal mothers” killing
their children contributes to the fear that untreated PPD can lead to postpartum psychosis
(Kaur 2004) and have a tragic end. PPD prevention programs are then established to
train health care workers to identify women with PPD and get them into treatment (Smith
2004). Hubert (2002) suggests the result is that more women willingly collude in their
own gender-biased diagnoses.

Defining Postpartum Depression
PPD is not a new phenomenon: Hippocrates described emotional difficulties of
the postpartum period thousands of years ago; in the mid-19th century, studies again
highlighted psychotic episodes but did not label PPD a separate illness (Kruckman and
Smith 2000). Nor is PPD a condition unique to western cultures (Dennis 2004), as
research shows PPD is reported to exist in a wide array of countries – among them
France, India, Turkey, Mexico, Cambodia, Brazil, Germany, Taiwan, China,
Czechoslovakia, Canada, Turkey, Malta, Sweden, and Korea.
In the United States today, the medical community does not label PPD a distinct
disease but views it as an affective disorder with characteristics similar to general
depression occurring in the postpartum period, generally six weeks following delivery
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(Kruckman and Smith 2000). Although the Diagnostic and Statistical Manual of Mental
Disorders (DSM) II listed PPD as a separate illness during the 1960’s, it eliminated the
category in 1980, stating that there was not enough evidence to consider it a distinct
disease (Kruckman and Smith 2000).
Weitz (2004) suggests that the DSM is problematic in that it often politicizes
diseases. She claims that although the DSM provides standardized diagnostic criteria for
mental illnesses, clinicians are often biased when applying them to female and/or
minority patients. A panel of experts decides what is considered a disease, which often
reflects historically-situated norms and values. For example, the DSM listed
homosexuality as a disease in the DSM until 1973, reflecting cultural values of that
period (Ford and Widiger 1989). A result of this method of disease classification is that
more African Americans than whites are diagnosed as paranoid schizophrenics with
violent tendencies, and more women than men are diagnosed as having depression and
histrionic personality disorder (Weitz 2004).
The Mayo Clinic Complete Book of Pregnancy and Baby’s First Year (Johnson
1994), available in the birth and pregnancy section of national bookstore chains,
categorizes PPD as an illness of the brain, which is susceptible to illness just like other
organs in the body (Johnson 1994:426). In addition to describing the sudden change in
hormones that occurs postpartum, the Mayo Clinic book, edited by a physician, lists
social factors which may contribute to PPD, including disappointment at not having the
mythical “perfect birth;” a response to postpartum pain or discomfort; a letdown from an
exciting event; concerns about dealing with the new baby; or surprise about the amount
of work involved in caring for the baby (Johnson 1994).
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Similarly, The National Women’s Health Information Center (2002) describes
PPD as “… a range of physical and emotional changes that many mothers can have after
having a baby.” It separates PPD into three distinct categories: the “baby blues,” which
occurs soon after childbirth and continues for one to two weeks; postpartum depression,
which starts anywhere from soon after to even a few months after childbirth and
continues for as long as one year; and postpartum psychosis, an extreme form of PPD
which usually begins within three months after childbirth. According to current medical
wisdom, the baby blues affect an estimated 50-80 percent of all new mothers, postpartum
depression affects between 3-20 percent, and postpartum psychosis affects approximately
.1 percent (or 1 per 1000 births) (Kruckman and Smith 2000).
Organizations such as Postpartum Support International (PSI) and Postpartum
Education for Parents (PEP) provide information about the malady as well as resources
for parents seeking assistance. They are often headed by medical doctors, psychiatrists,
Ph.D.s, and other experts, and encourage professional medical help for the mother as well
as support from family, friends, and support groups. They express the belief that the
disorder is caused by a combination of physical and social factors, specifically hormone
changes which affect brain chemistry and social stresses such as poor partner support and
social isolation. Consequently, emotional, social, and physical support are the
recommended remedies. The PEP website states:
Our society does not currently accept brain disease as it accepts physical
illness. There is a stigma about depressive disorders. The illness is difficult
to explain. Those closest to a depressed mother need to understand that while
psychological and environmental stress may play a role, depression is basically
a physical and chemical disorder. Give support, encouragement and hope. Your
assistance during this time of crisis is invaluable. (Logan 1989)
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Thus, the PEP website iterates a common bid for legitimacy, presenting PPD as a real
disorder with physical and social causes, and not “just in her head.”
PSI offers an anthropological approach to its analysis of PPD, stating that the
postpartum period in the United States is informally structured as compared to nonWestern, rural cultures in which extended families provide support during the postpartum
period. PSI characterizes the postpartum period in the United States as emotionally
draining, stressful and fatiguing; the baby blues and mid-levels of depression result from
modern birthing practices, the lack of clear role definition, and the lack of social support
for the new mother (Kruckman and Smith 2000). However, PPD is not unique to
Western culture, but is found in many non-Western countries as well.
The New Well Pregnancy Book (Samuels and Samuels 1996), a self-help book,
surmises that PPD results from feelings surrounding the birth process. Some mothers
expressed missing having the baby inside, as what once seemed to be a part of them was
not anymore; some found that with delivery the focus of attention shifted from them to
their babies. Other mothers reported feeling they were at fault for not having performed
better during childbirth, or felt that the hospital or staff cheated them out of the kind of
delivery they were expecting (Samuels and Samuels 1996). Another self-help book,
Conception, Pregnancy and Birth (Stoppard 2000) surmises that the sudden change in
hormone levels, personal or relationship problems, severe exhaustion, and the lack of
potassium, can lead to PPD. The book recommends such self-help strategies as rest,
proper diet, gentle exercise, and talking over feelings with others – especially one’s
partner – as remedies for PPD. In addition, psychiatric help, which includes
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antidepressants and mild sleeping pills, assists in recovery, according to the author
(Stoppard 2000). Medication is endorsed even when alternatives are given.

Symptoms and Treatment for PPD
According to Kruckman and Smith (2000), symptoms fall into physical,
emotional, and behavioral categories and vary by severity of PPD. Symptoms of the
baby blues are mild and last a few days to a few weeks, whereas postpartum depression is
marked by longer periods of depression. Physical symptoms range from lack of sleep, no
energy, and appetite changes to headaches, chest pains, heart palpitations, and
hyperventilating. Emotional symptoms run the gamut from anxiety and excessive worry,
confusion, sadness, and feeling overwhelmed or inadequate as a parent to hopelessness,
thoughts of suicide, bizarre hallucinations and incoherence. Behavioral symptoms range
from crying, oversensitivity, and irritability to panic attacks, hostility, and paranoia.
Postpartum psychosis is the most severe, with symptoms that may include extreme
confusion, loss of memory, inability to function, and possible harm to infant or self
(Kruckman and Smith 2000).
Treatment options vary widely and include psychiatric intervention,
psychotherapy, cognitive-behavioral therapy, antidepressants, antenatal classes,
relaxation techniques, educational strategies, social support during the postpartum period,
and more (Kruckman and Smith 2000). However, the efficacy of these approaches is
difficult to determine due to research design flaws, specifically small sample size and
exclusive sampling, that fail to determine the outcomes of such interventions (Dennis
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2004). Estimates of the prevalence of PPD vary due to unstandardized reporting
practices as well as to the vagueness in defining PPD.

PPD and Legislation
Legislation plays into the issue in several distinct ways. First, postpartum
depression is used as an insanity defense for some cases in which mothers harm or kill
their children. As mentioned in Chapter 1, Andrea Yates’ attorneys successfully
employed this defense, saving her from the death penalty and sending her to prison for
life (Colb 2003). The jury had to decide between two possibilities in determining her
fate: either Yates was a good mother who experienced temporary insanity, or Yates was
an evil monster who murdered her children (Colb 2003). Colb asserts that the insanity
defense could not spare her a life sentence because to accept her actions as a lapse from
sanity would shatter a benevolent view of motherhood, allowing the possibility that other
mothers could commit similar atrocities. Therefore, the jury convicted her out of the
need to hold her accountable and to keep other mothers from similar actions (Colb 2003).
In the Yates case, it is rarely disclosed that multiple factors converged that
resulted in the tragic deaths. Yates was treated for schizophrenia and depression after the
birth of her first child, and re-diagnosed after the birth of her fourth child. She, her
husband, and four small children lived in a cramped bus converted into a living space, but
shortly before the birth of their fifth child moved into a more spacious home. In addition,
she was influenced by religious fanaticism that led her to believe she was a bad mother
and that her children would be spared an eternity in hell if she murdered them. And her
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physician warned her husband and her after the birth of their fourth child that an
additional pregnancy could result in renewed mental problems; yet the responsibility of
caring for five young children after the birth of the fifth child fell solely on her. In
retrospect, Yates’ husband said the family knew of her illness but thought she was doing
well. They never suspected that she would kill her children (Couric and Morales 2005).
Legislation also enters into the PPD issue with the proposal of at least two bills,
not yet passed, to address PPD. The Melanie Blocker-Stokes Postpartum Depression
Research and Care Act (H.R. 846), introduced in February 2003 and referred to the
House subcommittee on Health later that same month, proposes mandated screening for
PPD. Its author, self-professed women’s health advocate Rep. Bobby L. Rush, D-IL,
states: “It’s time for us to recognize postpartum depression for what it is – a mental health
condition that requires medical treatment, not jail time” (Harris 2005). Rush states that
the overturn of Yates’ murder conviction in 2005 leads to a better understanding of
postpartum depression by the public as well as law enforcement officials, and that the bill
would help erase the stigma associated with PPD by recognizing it as a true illness
(Harris 2005). A second bill, House Bill 1427, introduced in the January 2005 Regular
Session and reintroduced in the January 2006 Regular Session, seeks funding for an
outreach campaign to educate people about PPD (Cook 2005). The sponsor of the bill,
Rep. Mary Helen Roberts, D-WA, said the bill would legitimate the condition as a
disease and remove the image of PPD that is the focus of jokes about “raging hormones”
(Cook 2005).
Even though it’s common and very treatable, many women don’t know
about postpartum depression and are afraid to seek help. The stigma of
mental illness hits doubly hard for women who are struggling with sadness
at a time when everyone expects them to be thrilled with their new baby. (Cook
2005)
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Impact of PPD on Family
Perhaps the most compelling argument used to garner support for its
medicalization is that PPD affects the family – the infant, the spouse, and older siblings.
Some studies claim that children with depressed mothers may exhibit long-term deficits
that affect the child beyond infancy to school age, such as inhibited speech development
and a weak mother-child relationship, due to the mother’s failure to interact with the
infant (Meltz 2003; Puckering 2005; Toneguzzi 2004). A Scottish study which provided
adult mental health services for new mothers found that deficits relating to the weakened
mother-child bond persist beyond when the mother’s depression ends (Puckering 2005).
In Barbados, researchers found that maternal depression, along with reduced infant
lengths and weights at 7 weeks, 3 months, and 6 months postpartum, were predictive of
lower scores on the Common Entrance Examination (CEE) for entry into high school, at
ages 11 to 12 years (Galler et al. 2004). A contrasting study found that cognitive
problems in the 4-year old children of depressed mothers showed no lingering effects
from PPD at the 7-year level, although the children were affected by such conditions as
low SES (Kurstjens and Wolke 2001), which typically is not treated.
Some literature on PPD finds that fathers can also experience PPD resulting from
additional stresses such as the mother’s depression, having an unsupportive relationship,
or being unemployed (Ballard and Davies 1996). Kleiman (2006) finds that 62 percent of
fathers suffer from the baby blues some time during the first four months following birth,
and 10 percent suffer from PPD. Paulson (2006), in his Early Childhood Longitudinal
Study involving 5,089 two-parent families, also asserts that approximately 10 percent of
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new fathers suffer from PPD, causing decreased interaction between father and infant
with implications for future development of the child. The deterioration of intimacy due
to lack of communication about the stresses of a new baby causes postpartum depression
in fathers, and 25 percent of all couples end their marriages within five years of having a
child (Parks 2005). Some symptoms of PPD in fathers include dramatic weight gain or
loss, difficulty sleeping, sadness, loss of interest in normal activities or hobbies, and
difficulty making decisions, due to the shift to parenthood (Smyth 2003). The finding
that fathers can experience PPD may rule out biological factors, such as hormones, as the
cause of PPD and place more emphasis on social or structural factors (Kleiman 2006). A
brief look at sociological literature finds no resistance to the concept that fathers can also
have PPD.
Currently, depression rating scales used for diagnosing PPD include the Hamilton
Rating Scale for Depression, the Edinburgh Postnatal Depression Scale (EPDS) (see
Appendix B), which are both used for detecting general depression, and the Beck
Depression Inventory (BDI) (see Appendix C), among others. The depression surveys
are administered by a health professional or may be completed by the patient, and higher
scores indicate higher levels of depression.

Feminism and PPD
Some feminist authors theorize that PPD is caused by such social factors as
isolation, severe stress, lack of partner support, and changing roles due to parenthood.
According to Taylor (1996), the dominant discourse surrounding PPD overlooks the
social construction of gender order as it expresses an essentialist belief in biological
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differences between women and men, resulting in conventional gendered power
dynamics.
As a structure, gender divides work in the home and in the wider
economy, legitimates existing hierarchies of authority, organizes sexual
expression and emotions, and structures every aspect of our lives because
of its embeddedness in the family, the work place, the state, as well as in sexuality,
language, and culture. (Taylor 1996:14)

Taylor stresses the role that media play in furthering discourse blaming mothers for all of
the ills of society and in echoing current political conservatism that calls for a return to
traditional family values. “Mothers, traditionally revered in the public discourse, are now
being portrayed as much more complex, even wicked, beings” (Taylor 1996:4). The
changing roles of women result in questions surrounding “appropriate” behavior
regarding such contemporary issues as working mothers, lesbian motherhood, single
motherhood, abortion and birth control rights, and the choice of self-identity outside of
motherhood. Taylor further asserts that the structure of families in modern society
creates problems of isolation and alienation. Support groups that arise in varied contexts
illustrate the impersonal quality of relationships, further complicated by the loss of close
extended family ties.
Modern social life is regulated more and more by the highly specialized,
technical, and impersonal knowledges of science, medicine, mental health,
the law, and other expert systems. These systems transmit technical knowledge
that influences how we experience almost every aspect of our lives – the
illnesses we suffer, the foods we eat, the medicines we take, the emotions
we express, our recreational habits, even how we experience sexual desire.
In modern self-help groups, people find a special space where they can develop
their own explanations of, and solutions to problems based, at least in part, on
everyday experience. (Taylor 1996:19)

Taylor (1996) finds that PPD support groups represent collective action for
redefining gender relations, a struggle to reflect disadvantages of gender through shared
experiences common in everyday life. Whereas obstetrical practices focus on biological
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aspects of motherhood and replace women’s experiential knowledge with scientific
knowledge, Taylor asserts that support groups empower women to resist traditional
ideologies of motherhood by allowing them to share their experiences of motherhood, to
build solidarity with other women, and to question traditional gender relationships within
the family. Such collective action represents “the renegotiation of motherhood taking
place through the discussion of postpartum illness” (Taylor 1996:11).
When women express their negative feelings, they experience themselves
as different from traditional – and ideal – mothers. Solidarity with other
women and the group consciousness that grows out of participation in
self-help makes it possible, however, for women to use cherished ideals
about motherhood for their own purposes ‘…to replace the myth of maternal
bliss with a more inclusive view of motherhood’ that is ‘more realistic and
accurate’ and places more emphasis on ‘the challenges and difficulties that
are part of the territory’ (Taylor 1996:142).

Taylor advocates forming support groups for PPD in order to force the medical
establishment to recognize PPD as a separate disease (Taylor 1996:154), which would
offer the advantages of lenient legal defense for mothers who injure themselves or their
babies as a result of PPD, insurance coverage for treatment, education projects for the
public on PPD, training for health professionals to recognize and treat PPD, and funding
for research on treatment and prevention (Taylor 1996:156). Additionally, support
groups would allow women’s experiential knowledge of birth and motherhood to counter
the ideological representations of motherhood that confine women to idealized versions
that often differ dramatically from reality.

Complicity of Drug Companies
Drug companies are business enterprises, requiring constant expansion of their
markets through innovation in product and marketing (Engler 2003; Diller 2005; Thomas
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2004; Johnston 2004). Their profitability relies on tweaking existing medications to form
“new drugs,” on expanding disease categories (for example, generalized depression to
include childhood depression and postpartum depression), and on marketing their
products to medical professionals and to the public (Angell 2004). The amount that drug
companies spend on direct-to-consumer advertisement more than tripled between 1996
and 2001, amounting to about $2.7 billion in 2001, and today reaching approximately $4
billion annually (Rowe 2006; Vendantam and Kaufman 2005). Dr. Lisa Schwartz
remarks on the results of drug advertising: “We’re increasingly turning normal people
into patients. The ordinary experiences of life become a diagnosis, which makes healthy
people feel like they’re sick” (Rowe 2006). Advertising drugs brings medical problems
to the individual level, medicalizing problems that once fell outside of the medical
domain and offering medication as a “quick but ultimately patient-centered fix” (Tone
and Watkins 2007: 7). Individuals pressure doctors to prescribe the advertised drugs, to
the extent that the typical American had 12 prescriptions a year by 2004, up from seven
prescriptions a year in 1994 (Rowe 2006).
Perhaps the worst part is that prescription drug ads have immersed us all in
a pervasive drug culture that seems to have no boundaries. We are being
reduced to helpless “consumers” who have no capacity to deal with challenges
other than by taking a pill (Rowe 2006: 9).
Drug companies control academic medical research through contracts with
academic institutions, and they receive government sponsorship of research projects,
resulting in research bias that removes the objectivity of scientific research and endangers
the health of consumers (Angell 2004; Krimsky 2003). Additionally, drug companies
benefit from monopoly rights that include patent protection and tax breaks for research
and development expenses.
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In his book, Let Them Eat Prozac: The Unhealthy Relationship between the
Pharmaceutical Industry and Depression (2004), psychiatrist David Healy maintains that
depression replaced nervousness, the psychiatric illness prevalent during the first eight
decades of the twentieth century. Tranquilizers were the preferred treatment for “nerves”
and were available over-the-counter or through prescriptions, making them widely
available to large numbers of individuals regardless of their socioeconomic status.
Although the use of tranquilizers began to wane in the 1970’s, it primed the population
for accepting psychotropic drugs to treat emotional symptoms. Healy states that
depression was rarely heard of prior to the development of Prozac; in order to market
antidepressants the pharmaceutical companies had to also market depression as a
treatable illness (Healy 2004). SSRIs replaced tranquilizers as the preferred treatment for
the new disease, depression.
Diller (2005) questions the practices of American psychiatrists in what he calls a
“drug culture,” the dramatic change toward medicating disorders such as depression and
hyperactivity which began in the early 1990’s. He finds that 9 out of 10 children under
the care of American psychiatrists are on one or more psychiatric drugs, whereas
European physicians and psychiatrists rely more heavily on other treatments (Diller 2005:
28). Although his study focuses on children’s health, he finds that drug companies
influence medical professionals by funding national physicians’ conferences, by offering
free samples of high-priced medications, by wooing physicians with free dinners and
consultant fees. In addition, drug companies hire expert witnesses to affirm the efficacy
and safety of their drugs, and they withhold findings which indicate ineffective, negative,
or harmful effects. Although drug companies are required to file negative reports with
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the Food and Drug Administration (FDA), they are not required to publish or make
public harmful outcomes. Diller maintains that the profit-driven drug companies are
most loyal to protecting the interests of their stockholders, even to the point of
endangering their customers.
Similarly, Thomas (2004) exposes fraudulent marketing practices which drug
companies use to gain profits, including suppressing research that contains negative data
about their products. In addition, she finds that drug companies promote drugs for offlabel use – that is, they encourage physicians to prescribe drugs approved for a specific
ailment for many other ailments. For example, she cites a study that found the makers of
the drug Neurontin, approved for the treatment of epilepsy, paid doctors to prescribe it for
manic depression, restless-leg syndrome, and other ailments. The drug company hired
ghostwriters to create articles promoting off-label uses of Neurontin and then paid
honorariums of $1000 to doctors who lent their names as authors to the articles. The
company was sued when a patient diagnosed with bipolar disorder attempted suicide
while taking Neurontin. Thomas asserts that the influence of drug companies is
enormous: the proportion of doctors to drug representatives is 2 to 1, and there is one
drug company lobbyist for every member of Congress (Thomas 2004).
The general public believes that drugs are federally regulated and therefore safe
for consumers once they are approved by the FDA. However, a committee report by the
Institute of Medicine, an affiliate of the National Academy of Sciences which advises
Congress on public health issues, finds that the FDA has limited funds and authority to
regulate licensed drugs once they are approved for consumer use (Nesmith 2006). Such
limitations weaken the FDA’s ability to protect and advance the public’s health, and fail
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to hold drug companies accountable for the safety of their products. The report criticizes
the use of fees paid by pharmaceutical companies to fund the FDA’s drug-approval
process – authorized by the 1992 Prescription Drug User Fee Act – as a conflict of
interest for the FDA which tilts the regulatory balance away from monitoring the safety
of drugs once they are approved. Further, the failure of the FDA to release negative
reports about the safety of drugs raises concerns about “the extent to which the
pharmaceutical industry has permeated the agency and how it may be influencing the
agency’s policies, practices and regulatory actions” (Koski 2004: 24).

CHAPTER 3
FINDINGS
Analysis of the articles from both databases reveals that the medical profession
perceives postpartum depression as a national health priority (Logsdon et al. 2005), a
significant public health problem whose incidence is second only to that of C-sections as
a birth-related complication (Buchwald 1980; Horowitz et al. 1995; Kirkey 1995; Forman
et al. 2000). The authors describe PPD as a well-known clinical phenomenon that has
always existed (Roland 1950; Unterman, Posner, and Williams 1990; Forman et al.
2000), a highly prevalent disorder (Nonacs et al. 2005), the “thief that steals motherhood”
(Goldbort 2005: 378) and takes the woman and her family by surprise (Beck and Gable
2000). It is one of the “darkest secrets of motherhood” (Kirkey 1995: C3), a “noteworthy
health problem” (Gentile 2005: 945), a “living nightmare” of uncontrollable anxiety
attacks, consuming guilt, obsessive thoughts and mood disturbance comparable to a
major depressive episode (Beck 1995).
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PPD is compared to other “dysfunctions” of women’s bodies such as menopause
(Roland 1950), premenstrual syndrome (Stowe 1995), “pregnancy dysphoria” which
includes postpartum blues and antepartum elements (Saks et al. 1985: 731), and
“premenstrual dysphoria” or PMS (Pearlstein et al. 1990: 132). Some “experts” believe
PPD may be on the rise, resulting in “tears and fears,” and despair that grows deeper as
time goes on (Bouchez 1995:7). The postpartum period is considered a time-limited
experience of enormous physiological and psychosocial adjustments and changes (Chen
et al. 2000), one of the most critical phases of a woman’s life beginning one hour after
delivery of the placenta (Gentile 2005).
The articles in the LexisNexis database that are written by medical professionals
or health reporters are similar in content to the Medline articles; however, there are three
non-medical types of articles on PPD in LexisNexis that differ from Medline. The first
contains news articles that report on related events such as deaths attributable to PPD or
proposed legislation. The second consists of arts columns with celebrity gossip (such as
the verbal exchange between Brooke Shields and Tom Cruise), art history (such as
prehistoric art depicts PPD) or reviews of books, movies or plays about PPD (such as
Shield’s autobiographical account of PPD, Down Came the Rain, or the movie Cotton
Mary whose main character suffers PPD). And the third has articles with metaphorical
references to postpartum depression. For instance, the term “postpartum depression” is
used as an analogy in which a long-term project is compared to childbirth in two of the
articles. The feeling of euphoria that one author experienced at a project’s completion
contradicts the presumed negative feeling that follows childbirth: “They say postpartum
depression is supposed to be painful…this doesn’t feel like pain” (Siegel 1990: 69).
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Similarly, Asimov (2005: F1) describes a feeling of despair which his subject felt at the
completion of a project, growing and harvesting grapes for his winery: “As he stared at
the cabernet sauvignon vines, which had just been harvested of grapes the day before, he
said, a sense of sadness and loss came over him. ‘It was the weirdest feeling, like
postpartum depression.’” These references connote an image of marking time, a letdown
occurring upon completion when the focus is no longer on the impending “birth” of the
project and a new focus has not yet come into view. The common use of the term in nonmedical sources indicates a general acceptance and understanding of the conditions
inherent to PPD among non-medical populations.
Non-medical discourse on postpartum depression brings more attention to the
issue, creating both proponents and opponents of the claim that it is a mental illness. For
example, a LexisNexis article reports on a radio station in New Jersey that was censured
after a disc jockey made flip on-air remarks about the postpartum depression that had
afflicted the wife of N.J. Acting Gov. Richard J. Codey. The author stated that the station
“has a long history of plunging into polarizing political issues, and shows no signs of
letting up” (Bruder 2005: 7).
The polarity of discourse is evident in many of the 2005 articles in the LexisNexis
database which refer to the debate between Tom Cruise and Brooke Shields over whether
PPD is a mental illness. Flagler (2005) cites the Cruise/Shields debate and suggests that
PPD is a potentially life-threatening illness, not a weakness, that can impair a new
mother’s ability to interact with her baby. She asserts that if depression is viewed as a
weakness, then women will not seek the help they need in fear that their baby may be
taken from them, and that comments such as Cruise’s “feed more fuel into the fire of
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denial” (Flagler 2005: C5). Shields rebuts Cruise’s criticism of the use of
antidepressants: “To suggest that I was wrong to take drugs to deal with my depression,
and that instead I should have taken vitamins and exercised, shows an utter lack of
understanding about postpartum depression and childbirth in general” (Bone 2005: G-8;
Miller 2005: CO3). Shields says she was overwhelmed by “feelings of doom,” and she
asserts that once PPD is recognized as a serious medical condition, then treatment will
become more available and socially acceptable (Bone 2005: G8). Shields also counters
Cruise’s attack on psychiatry, “It’s not the history of psychiatry, but it is my history,
personal and real” (Miller 2005: CO3).
In a review of Shields’ book on her experience with PPD, Neville (2005: G6)
reveals that Sheilds discloses “so many truly aberrant emotions,” such as feeling jealousy,
fear and rage when her husband held the baby while Shields was still on the operating
table in serious condition. The ideology of the good mother contrasts with reality as
Shields states she was expected to bond immediately with the baby but instead felt such
strong negative emotions; medication “pulled her back from the brink” when the feelings
continued over time (Neville 2005: G-6). Brody (2005: 7) also cites Shields’ book,
stating that PPD is extremely treatable, beyond a mother’s control, and that drugs are
“generally safe” even though they are excreted in breast milk and the effects are not wellstudied. Grove and Morgan (2005: 24) side with Shields (“the star”) against Cruise (“the
bit player”), sarcastically referencing Cruise’s vitamin cure for PPD: “Maybe the whole
PR offensive will be a vitamin boost to his career.” An editorial in the Omaha WorldHerald also refutes Cruise’s rant against psychiatry, stating that PPD is a “very real
concern for some women” and that “sophisticated drug research” has improved the lives
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of mentally ill residents of Nebraska (Omaha World-Herald 2005). Further, an article in
The Tampa Tribune calls Cruise a “know-it-all actor” who came unglued; a “zealous
practitioner of Scientology” who has no medical degree, a self-absorbed actor playing
with people’s lives, a strange and angry man.
Fortunately not many people will give him much credence. The view that
modern medicine can be too quick to prescribe antidepressants is hardly
out of the mainstream. But science has long proved that certain drugs can
effectively treat mental illness. Postpartum depression, in particular, is
treatable (The Tampa Tribune 2005: 12).

Expansion of Medical Control
We propose that thorough assessment of the mental health status of childbearing
Women is just as important as the many evaluations of biologic indicators of
health such as blood pressure readings, weight checks, and Papanicolaou smears
(Horowitz et al. 1995: 275).

The articles from both databases illustrate the expansion of the medical
profession’s control over pregnancy, childbirth and mothering beyond the physical to
include emotional and psychological aspects as well. This expansion is visible in the
increase in the number of articles published each year on postpartum depression (see
Table 1). The increase in frequency began before 1990, well before Andrea Yates
murdered her children in 2001, which indicates that PPD became a phenomenon without
a sensationalized introduction. Only seven of the articles in the sample mention such
sensationalized cases as Yates, although almost half suggest that PPD has dire
consequences for the child, 40 percent suggest harm to the mother, and 25 percent
suggest harm to the family.
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Table 1: Frequency of articles on PPD in the Medline and LexisNexis Databases
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The articles in the sample up to 1990 indicate that physicians recognized PPD in
some of their patients and tried remedies such as injections of the hormone alpha
estradiol, electroconvulsive shock therapy, or hospitalization, with the assumption that
PPD has biological causes such as hormonal imbalances (Roland 1950) or thyroid
malfunctions (Unterman et al.1990; Claman 1990) Other articles implicate social causes
of PPD, such as cultural expectations of motherhood that differ from reality (Beck 1995;
Beck 1995; Berchtold and Burrough 1990; Feingold 1995; Beck and Gable 2000;
Dankner et al. 2000; Leung, Martinson, and Arthur 2005; Goldbort 2005), body image
issues that influence public perception of pregnant and postpartum women and lead to
changes in their social lives, and the negative connotation of the term “housewife”
(Tentoni and High 1980: 247); and new coping mechanisms that are required as roles,
patterns, and relationships are renegotiated in parenthood (Gruen 1990).
Before 1990, remedies such as social support for new mothers exceed the
recommendation for counseling or medication: 43 percent (or three) of the seven articles
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up to 1990 recommend social support, 29 percent (or two of the articles) recommend
counseling, and 29 percent (or two of the articles) recommend medication (such as
hormone injections) as remedies (see Table 2). Practitioners offered

Table 2: Recommended treatment pre-1990 and 1990-2005.
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maternity/childbirth classes to dispel “myths” of pregnancy which women learned from
other mothers, replacing experiential knowledge with “factual” knowledge (Tentoni and
High 1980; Gruen 1990). The 102 articles in both databases from 1990 through 2005
recommend medication for the relief of symptoms more often (36 percent, or 36 of the
102 articles) than social support (31 percent or 31 of the articles) or counseling (28
percent or 28 of the articles). Support groups sponsored by medical personnel offered
women a chance to share their experiences with other mothers to discover that they are
not alone in their struggle with the illness, to feel less crazy, to learn that other women
get relief through the use of medication which is often necessary for recovery (Gruen
1990).
The articles in the total sample contend that the physical and emotional well-being
of the mother is vital for the health of the whole family (Ugarriza 2000), and harm to the
child is the most cited consequence of PPD: 48 percent (or 52 of the 109 articles in the
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entire sample) indicate that PPD causes harm to the child (see Table 3). Postpartum
depression results in a woman minimally functioning in her role as mother,

Table 3: Percentage of articles stating negative consequences of PPD
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afflicting the mother/infant bond (Vandenbergh 1980). The depressed mother’s
interaction with the infant promotes less-than-optimal development, and signs of PPD are
experienced as baby problems: “floppy helplessness, irritability, and feeding problems”
(Schwarzbeck 1995: 3E). Postpartum depression causes a mother to show little interest
in her infant, to be less affectionate and more withdrawn or intrusive and hostile
(Vandenbergh 1980), which interferes with the infant’s later well-being and predisposes
him/her to increased risk of suffering from “socioemotional, cognitive, and psychiatric
difficulties later in life” (Gentile 2005: 944). Its negative effects continue through
infancy into the teens and beyond. Postpartum depression also affects the spousal
relationship as women with PPD withdraw communication with their partner, have
decreased libido due to fatigue and dyspareunia (painful intercourse), and therefore the
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couple loses the “sexual expression of support” for each other in their transition to
parenthood (Martell 1990:92). Housework does not get done, babies become fussy, and
the woman can become unattractive and run down by fatigue, causing the family sorrow,
upheaval and disorganization (Martell 1990).
Postpartum depression is labeled “the most consistent predictor of future negative
parenting behaviors” including yelling, hitting, shaking (Halbreich 2005: 1317), and
children of depressed mothers are at increased risk of accidents, sudden infant death
syndrome, and higher frequency of hospital admissions (Forman et al. 2000). Depressed
mothers perceive their children as difficult, less adaptable to change, dependent and sober
with negative emotionality; and children of depressed mothers are socialized to respond
to mild stressors with anxiety (Whiffen 1990). Postpartum depression produces a
“compounded assault on the offspring’s physical and mental development and long-term
vulnerability to disorders” (Halbreich 2005: 1319).
The woman is subjectively portrayed in her role as mother, as solely responsible
for the health and well-being of the whole family. The mother is “burdened by an
overriding demand on her ability to love,” to focus on her sense of incapability to love or
to love sufficiently, while her spouse and other children “need reassurance they are still
recipients of love” (Vandenbergh 1980: 1109). Postpartum depression can incapacitate a
woman to the point where she is unable to take care of the infant, and thus the family
loses an “optimally functioning member;” by treating the mother, the entire family is
supported (Martell 1990: 91).
A woman’s relationship with her own mother is associated with vulnerability to
PPD, thus conveying the importance of establishing a strong mother/infant bond (Saks et
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al 1985; Trad 1995; Buist, Norman, and Dennerstein 1995). Negative memories of her
own experience with her caregiver may diminish a mother’s ability to form a positive
relationship with the infant, in turn affecting the infant’s ability to form healthy
relationships throughout life (Trad 1995). An emphasis on a mother’s “interpersonal
competence with the infant” suggests evaluating the mother’s interactions with the infant
and her “intuitive” parenting skills: visual cuing (maintaining eye contact), vocal cuing
(“baby talk” and verbalizing appropriate narrative), and holding behavior (firm yet gentle
grasp, holding infant close to body while gently caressing and verbalizing with infant)
(Trad 1995: 141). A mother’s failure to competently and confidently care for her infant
because of a poor role model or negative childhood experiences (such as childhood
sexual abuse) may lead to neglect and abuse with consequences that last a lifetime (Buist
and Barnett 1995). The implication is that physical, cognitive, and psychological
disorders are transferred from generation to generation through mothers, making PPD all
the more threatening.
To a lesser extent, the articles highlight the harm that PPD causes to the mother:
41 percent of the articles from both databases (44 of the 109 articles) suggest that
mothers suffer the effects of PPD. Postpartum depression is consistently associated with
the difficult transition to motherhood and the mother’s inability to adjust to her new role.
The articles indicate that the transition to motherhood leads to erosion of self-esteem and
feelings of inadequacy, possibly resulting from a sense of loss – of job or career, of
freedom, spontaneity, identity (Tentoni and High 1980; Gruen 1990). A new mother
loses control over many aspects of her life – relationships, lifestyle, bodily functions,
personal time (Stover and Marnejon 1995). Roles, patterns, and relationships have to be
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renegotiated, requiring new coping mechanisms (Gruen 1990). The woman experiences
a fear of her unfamiliar “state of self” and a lack of trust in her new role, feels she is a bad
mother who does not love her child enough, and struggles with the responsibilities
associated with being a wife and mother (Gruen 1990: 262). Her quality of life is
compromised because of the lack of positive emotions and interests, and she fears her life
will never return to normal (Trad 1995; Beck and Gable 2000). She suffers covertly,
enveloped in loneliness, consuming guilt, and obsessive thoughts (Beck 1995).
Just as medical professionals monitor the physical aspects of procreation from
conception to the postpartum checkup in order to prevent malfunctions, the emotional
and psychological aspects of childbirth are increasingly under medical control. This
expansion of the medical profession’s domain is visible in several areas of the postpartum
depression phenomenon, including its timing and its ever-growing list of symptoms. It is
evident in the varied health care professionals who are being alerted to recognize its
symptoms and implement the appropriate treatments, and in the development of new
screening instruments and screening programs to more accurately and thoroughly
diagnose PPD.

Reconstructing the “Post” Part of Postpartum
The DSM-IV defines PPD as “The presence of either depressed mood or
decreased interest or pleasure occurring persistently for two weeks and resulting in a
decline in functional status,” with onset occurring during the postpartum period,
generally the first four or six weeks after delivery (Garg, Morton, and Heneghan 2005).

40
Childbirth is considered the “triggering effect” to PPD, and any emotional complaint
after 10-14 days post-delivery should be considered abnormal (Stowe 1995: 640).
However, many researchers suggest that monitoring should be extended to include longer
postnatal periods, asserting that onset can occur later than suggested by the DSM-IV,
such as within three months after delivery (Roland 1950; Blenning and Paladine 2005),
up to six months after delivery (Garg et al. 2005; Stowe, Hostetter, and Newport 2005),
or a full year after delivery (Stover and Marnejon 1995). Handford (1985) finds that
mothers are vulnerable to depression within three years after giving birth; similarly, Garg
et al. (2005) find that many women with young children have symptoms of depression.
Buist and Barnett (1995) posit that mothering does not end after the postpartum period,
and Manfredi et al. (2005) suggest that not only childbearing mothers but grandmothers
should be assessed for PPD. The timeline for depression is gradually extended well
beyond the postpartum period, with some articles intimating an indefinite period of
vulnerability to PPD.
Many of the articles support the extended timeline for the onset of postpartum
depression. When the postpartum period is narrowly defined, women with late onset
depression are left undiagnosed, affecting prevalence rates that are much higher than
generally reported (Forman et al. 2000). Gruen (1990) asserts that PPD is rarely
diagnosed even though it may affect up to 20 percent of families with new babies. Beck
and Gable (2000) find that up to 50 percent of new mothers with PPD are undiagnosed;
similarly, Vandenbergh (1980) finds that up to 50 percent of new mothers may suffer
PPD. The importance of establishing an extended timeline for onset is that a delay in
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diagnosis and treatment results in longer duration of PPD episodes (Beck and Gable
2000) and a greater chance of recurrence (Trad 1995).
In addition to extending the timeline beyond the initial postpartum period as
described by the DSM-IV, many articles assert that onset occurs during pregnancy and
continues in the postpartum period (Vandenbergh 1980; Stowe 1995; Forman et al. 2000;
Goodnick et al. 2000; Glasser et al. 2000; Halbreich 2005; Carroll et al, 2005; Agoub,
Moussaoui, and Battas 2005; Stowe et al. 2005; Wissart, Parshad, and Kulkarni 2005;
Garg et al. 2005). As many as 25-35 percent of women supposedly have depression
during pregnancy (Goodnick et al. 2000), which increases the risk of PPD 2.5 to 4 times
(Bloch et al. 2000). Further, women with PPD are at a substantially increased risk for
depression in subsequent pregnancies (Bloch et al. 2000). A delay in diagnosis and
treatment during pregnancy occurs because of several reasons: the symptoms of
depression are often mistaken for normal conditions of pregnancy; women purposely
avoid fetal antidepressant exposure; and antenatal screening is not routinely performed
(Stowe et al. 2005).
Thus the articles convey an urgent need to begin screening for depression during
pregnancy. They assert that early diagnosis and treatment produce the best obstetrical
outcome and prevent negative consequences for the infant, the family, or the woman.
Recommended treatment most often includes medication, with its risk of harm to the
fetus or breastfed infant weighed against its benefit (Jermaine 1995; Rubin 2000). Rubin
(2000) asserts that studies that emphasize harm to the fetus when women take drugs in
pregnancy fail to note the implications when they do not take the medicine. Social
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support and counseling are recommended less frequently than medication. “The impact
of depression during pregnancy may still be controversial but the impact of stress/anxiety
is quite well-accepted” (Halbreich 2005: 1313).
A theme repeated throughout the articles is that depression consists of recurring
episodes. A prior episode of depression is the most often cited cause for developing
PPD, and 31 percent of the articles in the sample implicate prior depression as a major
cause of PPD. Medical professionals advise that early diagnosis and treatment are
necessary to prevent depression from becoming a chronic illness and to lessen the chance
of recurrence (Trad 1995). The finding that 53 percent of the women with PPD in one
study were depressed five years after delivery suggests that women with PPD may be
vulnerable to recurring episodes within four years, without undergoing another pregnancy
(Pop et al. 1995). This finding conveys the need to continue surveillance beyond even
the extended postpartum period, as exposure to subsequent relapse of maternal depression
beyond the first year increases the risk of diminished cognitive development and future
adversities for children when their mothers have PPD (Halbreich 2005; Logsdon et al.
2005; Gentile 2005). The risk of recurrence calls for a broad, comprehensive approach to
address the “multidimensional interactive processes” involved in the disease of PPD
(Halbreich 2005: 1319). With such dire consequences, doctors recommend the continued
use of medication for 9 to12 months after the depression remits in order to prevent
relapse (Stowe 1995; Horowitz and Goodman 2005).
The postpartum period is considered a developmental period in the life course
(Gruen 1990), temporal and transitional in nature, and some of the articles suggest that
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PPD is also transitional and remits on its own. Goodnick et al. (2000) assert that most
cases of PPD resolve naturally within three to six months; Blenning and Paladine (2005)
find that if left untreated, PPD lasts generally about seven months; and Beck (1995)
suggests that it remits within one year. However, these authors also suggest that better
screening increases diagnosis rates and facilitates identification and treatment of high-risk
women (Blenning and Paladine 2005); that medical professionals add to women’s shame,
embarrassment and guilt by suggesting that what they are feeling is normal (Beck 1995);
and that symptoms go beyond the patient, from the mother/infant duo to the entire family
(Goodnick et al. 2000). Thus, even though postpartum depression is considered a
temporary condition, medical intervention is encouraged.
Some of the articles indicate a reluctance to medicate pregnant or breastfeeding
mothers even while encouraging awareness and prevention of the disease. Corral, Kuan,
and Kostaras (2000) suggest the use of bright light therapy in lieu of medicating
breastfeeding mothers. Stowe (1995) finds that physicians are under consumer pressure
to diagnose and treat such conditions as PMS and PPD, even though the effects on the
infant’s nervous system are unknown and the side effects of antidepressants are similar to
PPD symptoms: anxiety, headache, and insomnia. Horowitz and Goodman (2005) find
that although the use of antidepressants improved the symptoms of depression for the
women in one study, other factors (such as the passage of time) may have contributed to
their recovery. Thus while PPD is a temporally-situated condition that apparently
resolves without treatment, and alternatives to medication exist, medical professionals
focus on improving diagnosis and treatment that most often includes medication.
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Tired, sleepless, happy…and other symptoms of PPD
The early articles tend to examine single biological, emotional, or social aspects
as possible causes of PPD, while some of the later articles move toward a multifactorial
focus on its causes. The most common causes of PPD (see Table 4) according to
the sample articles are prior depression or lack of family support; 32 percent of all the
articles in the sample suggest that a mother who suffered a previous episode of

Table 4: Causes of postpartum depression: percentages by year and by database
1950

1980

1985

1990

1995

2000

2005

Hormones

Medline
LexisNexis

100
0

50
0

50
0

43
0

29
63

33
13

28
24

Prior Depression

Medline
LexisNexis

0
0

50
0

0
0

43
0

50
13

39
13

50
10

Stress

Medline
LexisNexis

0
0

50
0

0
0

50
0

43
25

23
13

44
15

Family Support

Medline
LexisNexis

0
0

50
0

50
0

65
0

50
63

28
0

50
10

Marital Relationship

Medline
LexisNexis

0
0

50
0

0
0

57
0

36
50

22
0

45
5

Note: Percentages in Table 4 do not add up to 100 percent because some articles
mention multiple causes of PPD.
depression is at greater risk for PPD, and 36 percent suggest that lack of family support is
the main cause of PPD. Pop et al (1995) maintain that the most important predictors of
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PPD are prior depression and a family history of depression. Marital status and age of
the mother also make some women more vulnerable to PPD; 17 percent of all the articles
indicate that unmarried mothers are at greater risk for developing PPD, and 16 percent
suggest that young mothers have increased vulnerability, with the prevalence for
adolescent mothers as high as 47 percent (Logsdon et al. 2005).

Only four of the

articles (six percent) suggest that fathers can have PPD, and three (four percent) suggest
that other family members can have PPD.
The most cited biological symptoms include appetite changes, fatigue, and
insomnia. Emotional symptoms most often include anxiety, as well as sadness and/or
thoughts of suicide; behavioral symptoms include crying and irritability. Stover and
Marnejon (1995) suggest that symptoms of PPD are pleas for help by women to cope
with the emotional distress of motherhood. Horowitz et al. (1995) find that a “cluster of
symptoms” is more common in PPD than other depressive disorders: feeling worse in
evening, difficulty falling asleep; irritability; phobias; anxiety; OCD; sometimes suicidal
thoughts and anxiety disorders (see Table 5).
Saks et al. (1985) suggest that the relative well-being, joy and euphoria that
women feel immediately after giving birth may mask symptoms of depression and
therefore clinicians may miss symptoms of depression when the patient is discharged
from the hospital. “The relatively good mood shown by women at time of delivery is
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Table 5: Symptoms of postpartum depression: percentages by year and by
database.
1950

1980

1985

1990

1995

2000

2005

Anxiety

Medline
LexisNexis

0
0

100
0

100
0

43
0

50
50

34
13

28
5

Appetite Changes

Medline
LexisNexis

0
0

50
0

100
0

22
0

36
13

28
0

34
5

No Energy/Fatigue

Medline
LexisNexis

0
0

100
0

100
0

65
0

50
50

17
13

39
10

Insomnia

Medline
LexisNexis

0
0

100
0

100
0

50
0

57
50

39
13

50
15

Sadness

Medline
LexisNexis

0
0

100
0

100
0

43
0

29
38

17
0

28
5

Thoughts of Suicide Medline
LexisNexis

0
0

100
0

50
0

36
0

29
25

23
25

23
19

Note: Percentages in Table 5 do not add up to 100 percent because some articles mention
multiple symptoms of PPD.

worth stressing,” and may be labeled “postpartum pinks” in order to distinguish such
elation from the “normal” postpartum blues (Saks et al. 1985: 730). The positive
emotions exhibited following delivery are also implicated as signs of bipolar disorder, as
depression sets in after the initial highs of childbirth (Stowe 1995; Grof et al. 2000).
Thus medical professionals assert that mothers may be depressed even when they are
happy.
Several of the articles indicate that the symptoms of general depression are very
similar to the “normal” postpartum period – fatigue, weight loss, disturbances in eating
and sleeping patterns, mood disturbances, psychomotor retardation, change in body
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image, and loss of libido (Stowe 1995; Horowitz et al.1995; Johnson 2000; Ugarriza
2000; Maes et al. 2000; Stowe et al. 2005; Leung et al. 2005; Garg et al. 2005). The
overlap in symptoms associated with general depression and symptoms of the normal
postpartum period may lead to a failure to diagnose PPD (Horowitz et al.1995). Further,
women and their clinicians may mistake the symptoms of antenatal depression for those
of pregnancy (Stowe et al. 2005). Some authors suggest that women with PPD exhibit
more severe anxiety, panic attacks, crying spells, irritability, and hostility (Maes et al.
2000; Gentile 2005). For example, Boyer (1990) suggests that a new mother suffers
depression if she has 15 or more episodes of crying in any 60 days before or after
delivery. And Saks et al. (1985) find that depressed women self-rated themselves as
more lonely, angry at themselves, distressed, lacking feeling of well-being, angry at
others, shy, and defeated than non-depressed women. Thus medical researchers seek to
identify unique symptoms that suggest depression in postpartum women. To distinguish
between normal postpartum and antepartum conditions and PPD, Unterman et al. (1990)
assert that the DSM revision should have a separate diagnostic category that considers the
special problems that postnatal women have.
The distinguishing feature of PPD as proposed in the articles is mercurial mood
lability and an inability to adjust to the new responsibilities of motherhood (Stowe 1995;
Vandenbergh 1980; Saks et al. 1985; Gruen 1990; Unterman et al. 1990; Casiano 1990;
Trad 1995). The authors indicate that PPD is a form of “psychological morbidity”
(Forman et al. 2000: 1215; Gamble et al. 2005), one of several disorders occurring in the
antenatal and postnatal periods (Garg et al. 2005). Such disorders include bipolar
disorder (Stowe 1995; Grof et al. 2000; Heron, Craddock and Jones 2005), eating
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disorders (Franko and Spurrell 2000), post-traumatic stress disorder (Gentile 2005;
Gamble et al. 2005), postpartum obsessive-compulsive disorder (Horowitz and Goodman
2005), and a wide spectrum of anxiety disorders (Gentile 2005). It appears that PPD is
but one ailment that can negatively impact a woman’s life. Thus, the postpartum period
is “one of the most critical phases of a woman’s life” in which she is most likely to
develop PPD or severe psychiatric disorders, “especially the affective type” (Gentile
2005: 945).
Verkerk et al. (2005) suggest that personality plays an emerging role as a risk
factor for depression, asserting that neuroticism (characterized by tension, emotional
lability and insecurity) and introversion (inhibition and shyness in social situations)
predispose individuals to depression. Further, some women with depression are believed
to have “avoidant personality disorder” (Pearlstein et al. 1990: 132), which consists of
social inhibition, feelings of inadequacy, and sensitivity to negative evaluations; or they
may have a personality disorder such as alcoholism or drug abuse (Casiano 1990).

Call the Doctor
Some authors suggest that every postpartum woman needs a mental health
assessment just as she needs a physical assessment, and health care professionals have
unique opportunities to assess the functioning and adjustment of postpartum women
(Horowitz et al. 1995). However, health care professionals are just now becoming aware
of PPD (Feingold 1995). As a result, health care providers rarely see signs of PPD or
adjustment difficulties (Gruen 1990), possibly due to a lack of awareness or knowledge
of the disease or for a lack of time spent with each patient (Glasser et al. 2000). Thus,
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postpartum depression is rarely diagnosed even though up to 20 percent of families with
new babies are affected (Gruen 1990). However, the role of medical professionals
increasingly is to screen for depression (see Table 6).
Table 6: Recommended Course of Action for Medical Professionals to Mothers
100
Percentage

80
Screen

60

Educate
40

Support

20
0
1950 1980 1985 1990 1995 2000 2005
Ye ar of Publication

The primary source for medical care of the pregnant woman is the obstetrician,
who follows the progress of the pregnancy and the birth. The role of the obstetrician
generally ends with the postpartum checkup six weeks after delivery; therefore, other
health care professionals are being trained to recognize symptoms of PPD and identify
and treat women who may be depressed. PPD education for all “points of service” –
health care professionals in the obstetrical, primary care, and pediatric fields – provides
opportunities for early intervention to prevent harmful consequences to the entire family
(Garg et al. 2005: 592). The primary care physician, hospital support staff, nurses, and
social workers are alerted to look for signs of depression that include the patient’s words,
facial expressions, grooming, body language, and interaction with the infant (Auerbach
and Jacobi 1990; Berchtold and Burrough 1990). Midwives and childbirth educators play
an expanding role in the postpartum period by mentoring new mothers, educating them
about postpartum symptoms that are beyond the “normal” adjustment to parenthood for
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the sake of early detection and treatment (Feingold 1995). Clinicians are encouraged to
ask specific questions regarding the transition to motherhood in conversational style that
allows potentially depressed women to reveal stresses of their new parental roles (Beck
1995).
Casiano (1990) suggests that the goal of health care providers is to summarize
symptoms and label the disorder as maternity blues, mild to severe postpartum
depression, or postpartum psychosis, and to help the mother raise her children in a
healthier environment. Stover and Marnejon (1995: 1471) assert that physicians should
provide a comprehensive approach with “anticipatory guidance” for new mothers and
their families which gives them a more realistic view of pregnancy, childbirth, and
parenthood. Physicians are encouraged to focus on prevention through early
identification and treatment (Feingold 1995).
The nurses’ role expands to include assessing the emotional adaptation of women
to pregnancy and motherhood, and this assessment continues throughout the entire
childbearing cycle as well as through subsequent pregnancies (Auerbach and Jacobi
1990). Their knowledge of PPD is an essential aspect of caring; through intuition and
knowledge of PPD they can “make astute observations that something might be wrong
with the mother” and refer her to the appropriate source, guiding her to the path of
recovery (Beck 1995: 822). Nurses in the maternity hospital setting as well as those who
have outpatient contact with mothers, such as pediatric, obstetrical, and primary care
nurses, are asked to observe signs of maladaptation and to make appropriate referrals to
medical professionals for treatment (Auerbach and Jacobi 1990). In conversational style,
they convey empathy and assist the mother in obtaining support from family, neighbors
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or friends who can “mother the mother,” giving her food and rest from the demands of
motherhood (Auerbach and Jacobi 1990: 380; Kirkey 1995). They are encouraged to
observe tone and body language of mothers to detect signs of depression in “women in
the throes of illness,” to become educated about PPD by reading available literature and
attending lectures or conferences, and to implement postpartum support groups in the
hospital or community (Berchtold and Burrough 1990: 387). A further suggested role for
nurses includes to police compliance with recommended therapies to ensure that
depressed women follow through with the appropriate treatment (Horowitz and Goodman
2005). “Often the primary nurse must serve as the conduit through which the entire
health care team considers all family members’ needs” (Auerbach and Jacobi 1990: 383).
Health care providers often consider their work done when the physical health of
the mother and baby are attained after labor and delivery; however, their responsibility
continues into the postpartum period to ensure their psychological and emotional health
as well (Boyer 1990). A primary role for obstetricians and nurses whose patients are
pregnant women is preventing PPD by dispelling myths of pregnancy which first-time
mothers learn from experienced mothers (Tentoni and High1980). Maternity or
childbirth classes aim to replace lay knowledge with scientific, factual knowledge and
thereby counteract negative views of pregnancy and motherhood. Women’s experiential
knowledge is considered not only erroneous but harmful.

What’s your score?
Screening is a major component for diagnosing PPD, permitting intervention
before symptoms become disabling to the mother and harmful to the child. Some authors
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suggest the need for standardized screening instruments for optimal diagnosis, as well as
a broader set of risk factors that are more sensitive to PPD (Horowitz and Goodman
2005; Halbreich 2005). A popular depression screening tool, the Beck Depression
Inventory (BDI), is a 21-item questionnaire in which individuals self-rate their mood,
conscious thought, and symptoms of depression (Saks et al. 1985). However, the BDI
has been criticized because its questions are not specific to the childbearing experience, it
may miss some cases of subclinical depression, and the symptoms of postpartum
adjustment disorders are not differentiated from general depression (Horowitz et al.
1995). In addition, it may give false positives because it is sensitive to symptoms that are
“normal” changes after childbirth, such as sleep disturbances, weight loss, fatigue, and
loss of libido (Ugarriza 2000; Leung et al. 2005).
The Edinburgh Postnatal Depression Scale (EPDS) was designed specifically to
screen for PPD; it improves identification of high-risk women and diagnosis rates, and it
facilitates treatment (Ugarriza 2000; Blenning and Paladine 2005; Cox 2005). Its
limitations include that it does not provide mothers with an opportunity to describe their
symptoms fully (Beck 1995), that it only tests postpartum, not in pregnancy (Agoub et al.
2005), and that it lacks cultural relevance outside of western society (Banerjee et al.
2000).
Other screening tools include the Postpartum Depression Checklist (PDC), a
“simple practical device” designed to engage a woman in conversation about her
experiences with the 11 symptoms on the checklist (Beck 1995: 310), and the Antenatal
Psychosocial Health Assessment (ALPHA). ALPHA was designed to systematically
identify areas of psychosocial concern, listing 15 risk factors associated with woman
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abuse, child abuse, PPD, and couple dysfunction; it doubles the detection of psychosocial
concerns among pregnant women (Carroll et al. 2005).
Unterman et al. (1990) assert that women tend to underreport their symptoms
because of shame, guilt, or embarrassment, and that because of limited direct observation
by medical professionals, family members are responsible for recognizing symptoms of
depression in the mother and seeking medical help when necessary. Women may be
depressed at the postpartum checkup but unaware of diagnosis as they mistake distress as
the blues or fatigue; symptoms then evolve into a major depressive episode with impaired
functioning (Beck 1995). Psychosocial experiences interfere with a woman’s ability to
adjust to motherhood; therefore screening instruments with psychosocial values may
identify women at risk (Unterman et al. 1990). Horowitz and Goodman (2005) suggest
that the high prevalence and negative consequences of PPD require a change in
healthcare policy to mandate universal postpartum screening as standard care in the U.S.
Poor detection needs to be improved through tailored screening tools (Beck 1995) and
universal screening programs.

CHAPTER 4
DISCUSSION
Although PPD was recognized centuries ago during the time of Hippocrates, it
has only recently received much attention. The current sample of articles reflects a
trajectory of increasing volume since 1990 that illustrates the social narrative occurring
around the issue. That narrative changes over time, from examining the significance of
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single etiological elements, such as hormones or lack of family support, to a combination
of multiple factors that purportedly make women vulnerable to PPD. And although a
definitive etiology remains elusive, treatment options change from social support for
mothers in their childrearing responsibilities to medication as the current preferred
treatment recommended by medical professionals.
The articles illustrate, map, and justify an expansion of medical control over
women’s bodies to include not only physical aspects of childbirth but psychological and
emotional aspects of pregnancy and the postpartum period as well. The PPD issue
parallels the movement of childbirth into the medical model as women’s emotions are
pathologized, and as medical experts promote their knowledge to allegedly lower the risk
of harm to the baby, giving greater control to medical professionals while further eroding
women’s voice and agency. Just as Rothman (1982) finds it more difficult to have an
uncomplicated pregnancy – not because of complications but because of medical
intervention and innovative technology – it is becoming more difficult to be “normal” or
symptom-free in the postpartum. The extended timeline for vulnerability to onset, the
expanded list of symptoms specific to the postpartum, and the increased surveillance by
multiple medical practitioners and vague screening instruments push more women into
the complicated pregnancy category that includes clinical depression. And just as
obstetrical practices carve procreative time into specific categories that delineate
progression of the pregnancy, of the developing fetus, and of labor that disempower
women in the process of childbirth (Simonds 2002), medical professionals establish timedefined periods of postpartum, of vulnerability to onset of depression, and of duration of
the illness that affect women’s diagnoses.
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“Temporal differentiation” affects the way we classify the world, imbuing
meaning that becomes reified in everyday social life (Zerubavel 1991: 10). The articles
show an expansion in the timeline of surveillance of women’s moods, beginning in
pregnancy and continuing through an extended postpartum period that remains openended. Temporality is evident in the portrayal of the childbearing years as a
developmental period rife with vulnerability to psychiatric disorders, of which PPD is
only one. Women are said to be vulnerable to depression anywhere from 10-14 days
postpartum to three months, six months, one year, or five years and beyond, even into
grandmotherhood.
Temporality is also evident in the definition of PPD, as the time of onset of
symptoms lasting more than two weeks determines whether the woman is diagnosed with
the “normal” condition of “baby blues” or postpartum depression. The difference
appears to be not in the severity of symptoms but in the timing of onset and duration of
symptoms. And although some articles refer to PPD as a time-limited experience and
suggest that it readily remits without treatment within a few months to one year, the
articles convey a sense of urgency and crisis that requires immediate medical
intervention.
Intervention of medical professionals is encouraged through an education
campaign that informs obstetricians, pediatricians, primary care physicians, nurses, social
workers, hospital staff – and women – of the signs and symptoms of the disorder as well
as the dire consequences that occur when the malady is left untreated. When the mother
is fully functioning in her role, the infant supposedly attains optimal physical, emotional,
and cognitive development; the spousal relationship thrives; and the whole family is
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healthy, each member nurtured and loved by the mother. When the mother is not fully
functioning, the infant is dependent, fussy, neglected or abused, with physical, emotional
and cognitive impairment that affects future potential. The couple’s relationship is
threatened, filled with tension due to lack of communication, lack of sexual expression,
and the mother’s unattractive appearance. The family is disorganized, chaotic, stressed,
and in crisis. The education campaign promotes the intergenerational transfer of
depression with the assertion that the child’s future potential is stunted by the mother’s
depression, that children of depressed mothers are socialized to react to mild stress with
anxiety, and that a woman’s own experience of being mothered shapes her ability to
mother. Further, it conveys the urgency of curing depression for the sake of preventing
future episodes of depression, as a family history of depression or a prior episode of
depression is said to predispose women to PPD.
Medical professionals determine what is “normal” behavior for mothers, monitor
their conformity to these behavioral norms by observing and conversing with them, and
diagnose and treat those who are unable to fulfill such expectations. Personality, biology,
biography, and other individual traits are said to make some more vulnerable to failure to
develop an adequate maternal identity, thus causing PPD. The increased risk to certain
groups – young, unmarried, previously depressed women, women who faced childhood
adversities – is magnified in light of the ideology of the perfect mother, their
vulnerability to depression heightened because they are further from the ideal to start
with. The medical profession becomes a redeemer of sorts, the hero who removes the
blame from the miserable woman who struggles with ineptitude at motherhood.
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The influence of ideology on motherhood is ubiquitous. It causes mothers to feel
incompetent, overwhelmed, isolated and afraid to express negative emotions about the
mothering experience. The articles imply that the result of depression in mothers is harm
to the child (developmentally, emotionally, physically, cognitively), harm to herself (in
her maternal identity), and harm to the family (through stress, crisis, disorganization).
With such dire consequences, mothers who lack confidence to adequately care for and
love their infant succumb to medical control, possibly with relief through medication
such as Shields indicated. Blame and stigma are lessened as the difficulties in the
postpartum period are made real rather than imagined, given a name, common symptoms,
and treatment options that offer the hope of recovery. Few of the articles in the total
sample (six percent) indicate that fathers or other family members experience PPD,
although they are adversely affected by the woman’s depression.
It is important to note that the increase in frequency of articles coincides with the
1987 introduction of the first SSRI antidepressant, Prozac, to the U.S. market (Healy
2004; www.mayoclinic.com). The rate of depression in the general population since then
has increased 1000-fold (Healy 2004). Similarly, Bouchez (1995) asserts that there has
been either a true rise in incidence of PPD or an increase in those reporting its symptoms,
as the prevalence rate is closer to 30 percent than the 10-15 percent normally reported. In
addition, Hendrick (2000: 70) finds that the women with PPD in his/her study were 14
times more likely to be on two antidepressants than the non-postpartum depressed group,
and suggests that “polypharmacy” shows greater physician concern for postpartum
women that includes earlier use of additional psychotropic intervention. This finding
contradicts past medical practices that carefully spell out what should and should not be
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ingested during pregnancy and while breastfeeding. The suggestion that the risk of
medication to the developing fetus is less harmful than the effects of a mother’s
depression is a complete reversal from the pharmacologic abstinence usually practiced
during pregnancy.
While discourse surrounding postpartum depression opens the door for women to
express negative aspects of mothering without the risk of social condemnation, the
movement toward the medical model defuses pressure to remediate the tremendous and
disproportionate responsibility that mothers bear for the physical, emotional, and
cognitive development of their children. It leads to the diagnosis and treatment of
individual women rather than a change in the societal expectation that women be perfect
mothers. The focus is no longer on the difficulties of mothering and the dissonance
between ideological representations of motherhood and reality but on the scientific
representation of PPD as a disease. Women who fail to meet the standards of mothering
simply become patients, and medical professionals offer the hope of recovery.

Applied Implications
The emerging constructions of PPD represent the expansion of social control over
women’s bodies, not through overt oppression but through the medical diagnoses of
psychological and emotional disorders. In the spirit of inquiry about postpartum
depression’s effect on women’s lives, I question whether defining PPD as an illness, and
particularly prescribing medication as treatment, improves women’s lives. Although
medication may provide a “quick fix” for women suffering from depression in the
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postpartum, the practice of medicating social problems removes the potential for social
change as it locates the problem within the individual.
According to Taylor’s (1996) model of PPD, women’s self-help movements
redefine gender relations and renegotiate motherhood through the discussion of
postpartum illness in the popular advice literature. In support groups, women build
solidarity with others with shared experiences, enhance their feelings and perceptions
about themselves as well as their confidence when dealing with medical, legal, and other
professionals, and promote social and personal change. While I agree with Taylor that
support groups offer women a platform to convey their personal realities of motherhood
and that competing discourses arising from their shared experiences challenge traditional
notions of motherhood, I question whether social change would occur as a result. My
analysis shows that the medical profession increasingly recommends medication over
social support or counseling as the preferred treatment, which removes the impetus for
social change and instead finds its remedy in treating the individual mother. The
increased use of medication represents a change in direction of treatment since Taylor’s
book was published in 1996.
Ironically, Taylor finds that women are at the forefront of the push to have PPD
recognized as a distinct illness with its own categorization in the DSM. My study also
finds that more authors in my sample are women than men, and more medical doctors
than any other credential, which seems an anomaly. After all, how can one say that the
medicalization of PPD disempowers women and reflects the patriarchal nature of the
medical profession when it is women who are writing the articles? Perhaps an answer
may be found in Berger and Luckmann (1967: 85) who find that “subuniverses” of social
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meaning result from melding institutional knowledge with biography, illustrating “a
dialectic between social production and the objectivated world that is its product”:
A body of knowledge, once it is raised to the level of a relatively autonomous
subuniverse of meaning, has the capacity to act back upon the collectivity that
has produced it. For instance, Jews may become social scientists because they
have special problems in society as Jews. But once they have been initiated into
the social-scientific universe of discourse, they may not only look upon society
from an angle that is no longer distinctively Jewish, but even their social activities
as Jews may change as a result of their newly acquired social-scientific
perspectives. (Berger and Luckman 1967: 86-87, emphasis in original)
Established disciplines such as medicine train candidates in their traditions, and
regulatory practices such as review boards and certification requirements uphold the
practice of those disciplines. Women who enter the medical profession acquire medical
knowledge that is imbued with patriarchal values which influence their medical practice
and their perceptions of illness and disease.
The diagnosis of PPD infers disease from behavior, specifically failure to conform
to gender roles. When PPD is defined as an illness, women who receive a diagnosis
escape condemnation for failing at motherhood, after all, medicine is there to help the
mother, not to condemn. And a diagnosis has real advantages – in court, in building
solidarity among women, and in furthering discourse surrounding motherhood. But
locating women in the patient frame is helpful only up to a point; centering them in the
medical model pathologizes their experiences and removes agency. Mothers with PPD
are viewed as abnormal, deviating from the standards of maternal behavior. Women
diagnosed with PPD may be viewed as “patients” first and political actors second,
illustrating the potential for disempowerment because of the patient label. Having failed
at mothering, even if through no fault of their own, the label can be stigmatizing, can
limit their degrees of freedom and keep their primary status as “patient” rather than
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“woman.” And as patients, their demands for social reform become less imperative as
medicine is readily available to bring the struggling mother up to par. Medication pulls
mothers “back from the brink” and restores their ability to function as mothers. If the
behavior of women with PPD is viewed as irrational, it may lead others to view women
in general as irrational much as the focus on moods during the menstrual cycle and
menopause has negatively affected the perception of women’s emotional stability.
For an illness category so poorly defined and still debated, it is alarming and
perhaps premature that such practices as mandatory depression screening for all postnatal
women – legislated in New Jersey in 2006 and proposed in Illinois – are coming into
play, especially in light of screening instruments that are vague and difficult to interpret.
For instance, one of the 10 items on the Edinburgh Postnatal Depression Scale (EPDS)
states, “Things have been getting on top of me,” to which mothers are asked to underline
the response which comes closest to how they have felt in the past week:
Yes, most of the time I haven’t been able to cope at all
Yes, sometimes I haven’t been coping as well as usual
No, most of the time I have coped quite well
No, I have been coping as well as ever (see Appendix B).

Responses are scaled, and the total score determines the presence and severity of
depression, which then requires further clinical assessment.
The increasing rates of depression in pregnancy and the postpartum reflect
problems in living rather than a disease, and the medical model individualizes what might
be social issues of gender inequality. Clinicians should be aware that the diagnostic
category of PPD has a short social history with its recent constructions, and the potential
for over-prescribing medication exists, which can have detrimental effects on infant and

62
mother. Physicians rely on information supplied by pharmaceutical companies for new
products and approaches to treating illnesses, yet the long-term effects of antidepressants
on the fetus, on the breastfed infant, or on the mother have yet to be determined. The
question remains as to who benefits from diagnoses of depression – the mother, the
infant, medical professionals, or outside interests such as drug companies.

Theoretical Implications
Critical constructionists and postmodern feminists would recognize the imbalance
between the authoritative medical professional and the vulnerable woman. For instance,
women’s emotionality is often referred to as the “affective type” throughout the articles,
“aberrant emotions” associated with behaviors such as crying more than 15 times in any
60-day period. The gendered aspect of depression diagnoses is evident in the reference to
“postpartum pinks,” a state of elation immediately following childbirth that is said to
mask depression and possibly be a sign of bipolar disorder. Ironically, women are said to
be depressed even when they experience joy at childbirth. A comparable condition might
be a “runner’s high” which occurs following strenuous exercise or physical exertion;
would the same implication of bipolarity or masked depression apply to athletes, whose
composition includes both genders?
Medical professionals promote ideological representations of motherhood,
bolstered by such scientific concepts as “intuitive” mothering behaviors, which shape
maternal identities. Laden with ideology of the good mother, the articles romanticize
motherhood and support an unreachable standard by which all mothers are judged. The
focus is on the mother-infant dyad and intuitive mothering behaviors such as
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instantaneous mother/infant bonding, vocal and visual cuing, and maternal patterns of
empathic interaction with the infant. Idealized versions of motherhood and the perfect
transition from couple to family are portrayed as the “normal” state of motherhood.
Guilt, shame, depression, and sense of failure are the consequences of one’s failure to
attain. The cultural expectation that women will become mothers despite societal
attitudes that devalue motherhood creates a sense of disillusionment which new mothers
often describe as feeling angry, entrapped, isolated, and hostile. The articles implicate
the dissonance between such high expectations and reality, which creates a sense of
failure for mothers. The influence of the medical profession on women’s maternal
identities supports feminist and constructionist recognition of imbalances of power.
The assertion that mothers are unaware that they are depressed, that they mistake
their symptoms for those of fatigue and lack of sleep supports Foucault’s theoretical
assertion that individuals undergo a process of self-understanding mediated through an
external authority figure, in this case the medical professional. Screening instruments
assume knowledge of all women’s experiences in the motherhood role and assess their
ability to adapt based on those assumptions. Foucault asserts that the individual is the
ideological representation of society, but power (specifically biopower) produces reality,
domains of objects and rituals of truth anchored in consensual relationships. Power, then,
is not a pure and simple projection upon individuals but is enforced through a multitude
of institutions – medicine, the family, religion, the state. Through scientific
classification, the individual defines who they are; normative expectations tell us how to
behave and what actions to take. The ideology of the “good mother” supported in the
articles tells us what motherhood should be and what mothers should experience.
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Presented as truth, experts present a normative ideal of motherhood that constructs the
standards of motherhood. Thus, the power of medical experts’ knowledge normalizes the
expectations of motherhood by which all women are judged.
Women who undergo screening evaluate their own experiences through the
preconceived representations on the screening instrument. Their mothering experiences
are framed through the eyes of the medical profession and upheld through the influence
of family, religion, and state policies, setting standards for mothering that shape maternal
identities. Disciplinary power through surveillance – by medical authorities, family, and
state policies – results in the objectification of women who self-diagnose according to the
checklists of symptoms, and the individual woman regulates and achieves conformity to
the normative expectations of motherhood by seeking medical intervention when
necessary. As Foucault asserts, normalizing individuals occurs within the body of people
and optimizes the well-being of each individual; it is used for the good of the state and to
protect the lives of its people. This is visible in the issue of PPD, as the medical
profession creates an image of motherhood which society accepts and allows it to shape
its attitudes and actions toward motherhood. Medicalization operates as social control at
the “capillary level” (Foucault 1980: 39), not from above or below but from all social
relationships, constraining individual bodies and governing individual actions and
attitudes through the discourse of PPD. Through ideological representations and medical
categorization, women conform to societal expectations of motherhood; through
medication, the depressed woman becomes a good mother for the protection and
nurturing of the infant and the family. Thus the medical model and the current
constructions of PPD produce Foucault’s concept of docile bodies.
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Conformity to the standards of motherhood occurs as discourse strengthens the
ideal as the norm, as in Gramsci’s concept of hegemony. Mothers willingly conform to
treatment protocols because “experts” deem that treatment to be in their best interest for
the health and protection of the infant and family. The authority which the medical
profession exerts in the discursive formation of PPD can be seen in the Tom
Cruise/Brooke Shields debate. Authors of the LexisNexis articles in the sample quickly
renounced Cruise’s statements as a rant and an irresponsible disservice to women. They
pointed out his lack of a medical degree as evidence that he is unqualified to speak about
the issue. Although his message may have been valid, the focus became his irrational
behavior, awarding a point to the medical side and a penalty to those who would question
medical intervention for PPD, furthering medical dominance and control in the
postpartum debate.

CONCLUSION
Analysis of a sample of medical and popular literature on postpartum depression
shows that the process of medicalization extends medical control over women’s lives
during the childbearing years beyond the physical to include emotional and psychological
aspects as well. The articles in both the Medline and LexisNexis databases are similar in
their medical representations of PPD; some of the articles in the LexisNexis database also
present PPD in non-medical context. The common use of the term in non-medical
sources indicates a general acceptance and understanding of the conditions inherent to
PPD among non-medical populations.
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The expansion of the medical domain is evident in the timing of onset – which
now extends well beyond the traditional four- to six-weeks postpartum as well as back
into pregnancy – and the evolving list of depressive symptoms unique to pregnant and
postpartum women. The expansion is also evident in the number of professionals in
various medical fields – obstetrics, pediatrics, family practice, nursing, psychiatry, social
work – trained to diagnose and treat PPD, as well as in the development of new screening
instruments and programs designed specifically to identify women at risk.
The emphasis on monitoring women’s moods and treating women in order to
support the family tightens the boundaries of motherhood, enforcing cultural ideologies
of the good mother. The expectations of motherhood are more firmly set as the medical
profession defines what emotions are normal in the transition to motherhood. The
medicalization of PPD results in the treatment of individual women, most often with
medication, with negative implications for women that include the label of “patient” that
sticks and results in a lifetime of surveillance, the pathology of normal emotions as
“aberrant” rather than human, and with such practical concerns as hindering the ability to
obtain life insurance once diagnosed with PPD (Lieber 2007). The mother alone
experiences PPD in the transition to parenthood; fathers and other family members are
rarely diagnosed with PPD but are said to suffer the effects of the mother’s depression.
Ideological representations of motherhood – such as intuitive mothering behaviors and
expectations of joyful mothering experiences – coupled with adverse, long-term
consequences to the child and the family when such ideals are not attained compel
women to seek treatment. Rather than ameliorating the effects of a difficult transition
through social support, medication is the preferred remedy for the individual mother who
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struggles in her motherhood role. Thus, medicalization standardizes emotions and
behaviors that support idealized versions of motherhood and upholds gender inequality
inherent in traditional parenting roles.
The increase in the frequency of articles and the education campaign to raise
awareness about PPD coincide with the 1987 introduction of the SSRI antidepressant
Prozac to the U.S. market. The shift away from social support to medication as the
preferred treatment implicates the marketing of pharmacology in the push to establish
PPD as a treatable disease. The education campaign to inform medical professionals and
mothers about the signs and symptoms of PPD produces more “awareness” about the
disease, and treatments are designed to prevent harm to the child and to lessen the risk of
recurring episodes of depression. Women who experience an episode of depression will
be under increased scrutiny during each subsequent pregnancy, postpartum period, and
any future stressful life event, expanding medicine’s gaze into women’s lives. With this
marketing strategy, the prevalence rates of mothers who are depressed increase…as do
profits for the drug companies. Yet the fate of not only the present but the future remains
heavily on the woman’s shoulders. The hierarchy of medical authority reinforces gender
inequality as it more firmly establishes women’s role as the primary caregiver for
children.
The push to screening for depression in the pre-partum and in longer periods
postpartum and to medicating women who are diagnosed raises the alarm to unravel the
process of medicalization rather than accept it. A close reading of a careful sample of
both medical and popular sources reveals nuances in the ways that medicine and
medicalization play out, not only furthering the scientific rationale for expanded controls
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over women’s lives, but also justifying pharmaceutical involvement. As a result, I come
away with a picture of the process as entrenching the hierarchy of medicine and
tightening the boundaries of motherhood.
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PhD
6
LPC
3
PsyD
7
Other (Specify) ___________
4
RN, LPN
9
Don’t know
10
Not applicable
19. Gender of author: 1
Male
2
Female
9
Don’t know 10
Not applicable
Name of 6th author _______________________________________________________
20. Credentials of author:
1
MD
5
LCSW
2
PhD
6
LPC
3
PsyD
7
Other (Specify) ___________
4
RN, LPN
9
Don’t know
10
Not applicable
21. Gender of author: 1
Male
2
Female
9
Don’t know 10
Not applicable
Name of last author ____________________________________________________
22. Credentials of author:
1
MD
5
LCSW
2
PhD
6
LPC
3
PsyD
7
Other (Specify) ___________
4
RN, LPN
9
Don’t know
10
Not applicable
23. Gender of author: 1
Male
2
Female
9
Don’t know 10
Not applicable
24. Sponsor of article:
1
Pharmaceutical company
2
Medical practice
3
Professional organization

4
9

Other (Specify) ___________
Don’t know

Section 3
What, according to the article, causes PPD?
Biology
25. Hormones?
1 Yes
2 No
9 Don’t know
26. Sleep Deprivation?
1 Yes
2 No
9 Don’t know
27. Diet?
1 Yes
2 No
9 Don’t know
28. Other biological cause? (Specify) ________________________________
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1 Yes

2 No

9 Don’t know

Psychology
29. Prior Depression?
1 Yes
2 No
9 Don’t know
30. Stress?
1 Yes
2 No
9 Don’t know
31. Coping skills?
1 Yes
2 No
9 Don’t know
32. Perfectionism?
1 Yes
2 No
9 Don’t know
33. Self-esteem?
1 Yes
2 No
9 Don’t know
34. Childhood experiences or trauma?
1 Yes
2 No
9 Don’t know
35. Other psychological cause? (Specify) _____________________________
1 Yes
2 No
9 Don’t know
Social
36. Family support?
1 Yes
2 No
9 Don’t know
37. Marital relationship?
1 Yes
2 No
9 Don’t know
38. Friends?
1 Yes
2 No
9 Don’t know
39. Other social cause? (Specify) ____________________________________
1 Yes
2 No
9 Don’t know
Section 4
Does the article infer implicitly or explicitly that some individuals are more vulnerable or
at risk for PPD based on biographical characteristics?
40. Age?
1 Yes
2 No
9 Don’t know
41. Marital status
1 Yes
2 No
9 Don’t know
42. Low SES
1 Yes
2 No
9 Don’t know
43. Race
1 Yes
2 No
9 Don’t know
44. Ethnicity
1 Yes
2 No
9 Don’t know
45. Other biographical characteristics? (Specify)________________________
1 Yes
2 No
9 Don’t know
Section 5
What, according to the article, are the symptoms of PPD?
Physical:
46. Insomnia
1 Yes
2 No
9 Don’t know
47. No energy / fatigue
1 Yes
2 No
9 Don’t know
48. Appetite changes
1 Yes
2 No
9 Don’t know
49. Headaches
1 Yes
2 No
9 Don’t know
50. Chest pains
1 Yes
2 No
9 Don’t know
51. Heart palpitations
1 Yes
2 No
9 Don’t know
52. Hyperventilating
1 Yes
2 No
9 Don’t know
53. Other physical symptoms (Specify) _______________________________
1 Yes
2 No
9 Don’t know
Emotional:
54. Anxiety
1 Yes
2 No
9 Don’t know
55. Excessive worry
1 Yes
2 No
9 Don’t know
56. Confusion
1 Yes
2 No
9 Don’t know
57. Sadness
1 Yes
2 No
9 Don’t know
58. Feeling overwhelmed
1 Yes
2 No
9 Don’t know
59. Feeling inadequate as a parent
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1 Yes
2 No
9 Don’t know
60. Incoherence
1 Yes
2 No
9 Don’t know
61. Feeling of hopelessness 1 Yes
2 No
9 Don’t know
62. Thoughts of suicide
1 Yes
2 No
9 Don’t know
63. Hallucinations
1 Yes
2 No
9 Don’t know
64. Other emotional symptoms (Specify) _____________________________
1 Yes
2 No
9 Don’t know
Behavioral:
65. Crying
1 Yes
2 No
9 Don’t know
66. Oversensitivity
1 Yes
2 No
9 Don’t know
67. Irritability
1 Yes
2 No
9 Don’t know
68. Panic Attacks
1 Yes
2 No
9 Don’t know
69. Hostility
1 Yes
2 No
9 Don’t know
70. Paranoia
1 Yes
2 No
9 Don’t know
71. Other behavioral symptoms (Specify) ____________________________
1 Yes
2 No
9 Don’t know
Section 6
Does the article reference a distinction in intensity of PPD?
72. Baby blues
1 Yes
2 No
9 Don’t know
73. Postpartum Depression 1 Yes
2 No
9 Don’t know
74. Postpartum Psychosis
1 Yes
2 No
9 Don’t know
75. Does the article reference the prevalence of the baby blues (in terms of % of all new
mothers)?
1
Yes (Specify range): From ____% to _____ % of all new mothers
2
No
9
Don’t know
76. Does the article reference the prevalence of PPD (in terms of % of all new mothers)?
1
Yes (Specify range): From ____% to _____ % of all new mothers
2
No
9
Don’t know
77. Does the article reference the prevalence of postpartum psychosis (in terms of % of
all new mothers)?
1
Yes (Specify range): From ____% to _____ % of all new mothers
2
No
9
Don’t know
Does the article suggest that others can have PPD?
78. Father?
1 Yes
2 No
9 Don’t know
79. Other family members? (Specify) ________________________________
1 Yes
2 No
9 Don’t know
80. Friends?
1 Yes
2 No
9 Don’t know
Section 7
Does the article suggest an effective treatment for PPD?
81. Medication?
1 Yes
2 No

9 Don’t know
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82. Counseling?
1 Yes
2 No
9 Don’t know
83. Social support?
1 Yes
2 No
9 Don’t know
84. Combination (Specify) _____________________________________
1 Yes
2 No
9 Don’t know
85. Other treatment (Specify) ___________________________________
1 Yes
2 No
9 Don’t know
Section 8
Does the article mention consequences of PPD?
86. Harm to child?
1 Yes
2 No
9 Don’t know
87. Harm to mother?
1 Yes
2 No
9 Don’t know
88. Harm to spouse?
1 Yes
2 No
9 Don’t know
89. Harm to family?
1 Yes
2 No
9 Don’t know
90. Harm to society?
1 Yes
2 No
9 Don’t know
91. Harm to other (Specify) _______________________________________
1 Yes
2 No
9 Don’t know
92. Does the article mention extreme cases of PPD (e.g., Yates)?
1 Yes
2 No
9 Don’t know
Section 9
What is the role of medical professionals in PPD?
Does the article recommend proactive intervention such as
Screening…
93. for new mothers?
1 Yes
2 No
9 Don’t know
94. for new fathers?
1 Yes
2 No
9 Don’t know
Educating…
95. Mothers?
1 Yes
2 No
9 Don’t know
96. Fathers?
1 Yes
2 No
9 Don’t know
97. Health care professionals? (Specify) _________________________________
1 Yes
2 No
9 Don’t know
Support
98. for new mothers?
1 Yes
2 No
9 Don’t know
99. for new fathers?
1 Yes
2 No
9 Don’t know
100. for health care professionals?
1 Yes
2 No
9 Don’t know
-----------------------------------------------------------------------------------------------------------Comments about the article or selected quotes:
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Appendix B
Edinburgh Postnatal Depression Scale (EPDS)
Taken from the British Journal of Psychiatry June, 1987, Vol. 150 by J.L. Cox, J.M.
Holden, R. Sagovsky

( In www.childbirthsolutions.com )

The Edinburgh Postnatal Depression Scale has been developed to assist primary care
health professionals to detect mothers suffering from postnatal depression; a
distressing disorder more prolonged than the "blues" (which occur in the first week
after delivery) but less severe than puerperal psychosis. Previous studies have
shown that postnatal depression affects at least 10percent of women and that many
depressed mothers remain untreated. These mothers may cope with their baby and
with household tasks, but their enjoyment of life is seriously affected and it is
possible that there are long-term effects on the family.
The EPDS was developed at health centers in Livingston and Edinburgh. It consists of
ten short statements. The mother underlines which of the four possible responses is
closest to how she has been feeling during the past week. Most mothers complete
the scale without difficulty in less than 5 minutes.
The validation study showed that mothers who scored above threshold 92.3percent
were likely to be suffering from a depressive illness of varying severity. Nevertheless
the EPDS score should not override clinical judgment. A careful clinical assessment
should be carried out to confirm the diagnosis. The scale indicates how the mother
has felt during the previous week and in doubtful cases it may be usefully repeated
after 2 weeks. The scale will not detect mothers with anxiety neuroses, phobias or
personality disorder.
Instructions for users:

1. The mother is asked to underline the response which comes closest to how
she has been feeling in the previous 7 days.

2. All ten items must be completed.
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3. Care should be taken to avoid the possibility of the mother discussing her
answers with others.

4. The mother should complete the scale herself, unless she has limited English
or has difficulty with reading.

5. The EPDS may be used at 6-8 weeks to screen postnatal women. The child
health clinic, postnatal check-up or a home visit may provide suitable
opportunities for its completion.

****
Name: _______________________________
Address: ___________________________________________________
Baby's Age: __________________
As you have recently had a baby, we would like to know how you are feeling. Please
UNDERLINE the answer which comes closest to how you have felt IN THE PAST 7
DAYS, not just how you feel today.

1. I have been able to laugh and see the funny side of things.

2.

As much as I always could
Not quite so much now
Definitely not so much now
Not at all
I have looked forward with enjoyment to things.
As much as I ever did
Rather less than I used to
Definitely less than I used to
Hardly at all

3. * I have blamed myself unnecessarily when things went wrong.
Yes, most of the time
Yes, some of the time
Not very often
No, never

4. I have been anxious or worried for no good reason.
No, not at all
Hardly ever
Yes, sometimes
Yes, very often

5. * I have felt scared or panicky for not very good reason.
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Yes, quite a lot
Yes, sometimes
No, not much
No, not at all

6. * Things have been getting on top of me.
Yes, most of the time I haven't been able to cope at all
Yes, sometimes I haven't been coping as well as usual
No, most of the time I have coped quite well
No, I have been coping as well as ever

7. * I have been so unhappy that I have had difficulty sleeping.
Yes, most of the time
Yes, sometimes
Not very often
No, not at all

8. * I have felt sad or miserable.
Yes, most of the time
Yes, quite often
Not very often
No, not at all

9. * I have been so unhappy that I have been crying.
Yes, most of the time
Yes, quite often
Only occasionally
No, never

10. * The thought of harming myself has occurred to me.
Yes, quite often
Sometimes
Hardly ever
Never
Response categories are scored 0, 1, 2, and 3 according to increased severity of the
symptoms. Items marked with an asterisk are reverse scored (i.e. 3, 2, 1, and 0).
The total score is calculated by adding together the scores for each of the ten items.
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Appendix C
Beck Depression Inventory (BDI)
Choose one statement from among the group of four statements in each question that best
describes how you have been feeling during the past few days. Circle the number beside your
choice.
1 0 I do not feel sad.

8

1 I feel sad.

1 I am critical of myself for my weaknesses or
mistakes.

2 I am sad all the time and I can't snap out of
it.
3 I am so sad or unhappy that I can't stand it.
2 0 I am not particularly discouraged about the
future.

0 I don't feel I am any worse than anybody else.

2 I blame myself all the time for my faults.

9

3 I blame myself for everything bad that happens.
0 I don't have any thoughts of killing myself.

1 I feel discouraged about the future.

1 I have thoughts of killing myself, but I would not
carry them out.

2 I feel I have nothing to look forward to.

2 I would like to kill myself.

3 I feel that the future is hopeless and that
things cannot improve.
3 0 I do not feel like a failure.
1 I feel I have failed more than the average
person.

3 I would kill myself if I had the chance.
10 0 I don't cry any more than usual.
1 I cry more now than I used to.
2 I cry all the time now.

2 As I look back on my life, all I can see is a lot
of failure.
3 I feel I am a complete failure as a person.
4 0 I get as much satisfaction out of things as I
used to.

3 I used to be able to cry, but now I can't cry even
though I want to.
11 0 I am no more irritated by things than I ever am.
1 I am slightly more irritated now than usual.

1 I don't enjoy things the way I used to.
2 I don't get any real satisfaction out of
anything anymore.

2 I am quite annoyed or irritated a good deal of the
time.
3 I feel irritated all the time now.

3 I am dissatisfied or bored with everything.
5 0 I don't feel particularly guilty.
1 I feel guilty a good part of the time.

12 0 I have not lost interest in other people.
1 I am less interested in other people than I used to
be.

2 I feel quite guilty most of the time.
2 I have lost most of my interest in other people.
3 I feel guilty all of the time.

83

6 0 I don't feel I am being punished.

3 I have lost all of my interest in other people.
13 0 I make decisions about as well as I ever could.

1 I feel I may be punished.

1 I put off making decisions more than I used to.

2 I expect to be punished.

2 I have greater difficulty in making decisions than
before.

3 I feel I am being punished.
7 0 I don't feel disappointed in myself.

3 I can't make decisions at all anymore.
14 0 I don't feel that I look any worse than I used to.

1 I am disappointed in myself.

1 I am worried that I am looking old or unattractive.

2 I am disgusted with myself.

2 I feel that there are permanent changes in my
appearance that make me look unattractive.

3 I hate myself.
3 I believe that I look ugly.

15

0 I can work about as well as before.

19

1 It takes an extra effort to get started at doing
something.

0 I haven't lost much weight, if any, lately.
1 I have lost more than five pounds.
2 I have lost more than ten pounds.

2 I have to push myself very hard to do
anything.

3 I have lost more than fifteen pounds.

3 I can't do any work at all.
16

0 I can sleep as well as usual.

20

(Score 0 if you have been purposely
trying to lose weight.)
0 I am no more worried about my health
than usual.

1 I don't sleep as well as I used to.
1 I am worried about physical problems
such as aches and pains, or upset
stomach, or constipation.

2 I wake up 1-2 hours earlier than usual and
find it hard to get back to sleep.

2 I am very worried about physical
problems, and it's hard to think of much
else.

3 I wake up several hours earlier than I used
to and cannot get back to sleep.

17

0 I don't get more tired than usual.

21

3 I am so worried about my physical
problems that I cannot think about
anything else.
0 I have not noticed any recent change in
my interest in sex.

1 I get tired more easily than I used to.
1 I am less interested in sex than I used
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2 I get tired from doing almost anything.

to be.

3 I am too tired to do anything.

2 I am much less interested in sex now.
3 I have lost interested in sex completely.

18

0 My appetite is no worse than usual.
1 My appetite is not as good as it used to be.
2 My appetite is much worse now.
3 I have no appetite at all anymore.
SCORING

1 – 10: These ups and downs are considered normal.
11 – 16: Mild mood disturbance
17 – 20: Borderline clinical depression
21 – 30: Moderate depression
31 – 40: Severe depression
over 40: Extreme depression
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